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Abstract 
Efforts to create a mycolactone-negative mutant of Mycobacterium u/cerans via 
transposon mutagenesis were undertaken to elucidate the genes involved in the 
production of this toxin. Though only five PCR-confirmed insertion mutants were 
produced, one of these, 1615:tnp6w, was confirmed to be deficient in mycolactone 
production via thin-layer chromatography (TLC) of acetone soluble lipids (ASLs), 
cytopathicity assay of culture filtrate on L929 fibroblasts, and mass spectroscopy of 
ASLs. Using nested-PCR, it was determined that the transposon insertion of 1615:tnp6w 
had occurred in a region of DNA containing a gene 97% identical to the M marinum 
ferric uptake regulator homo log (FurA) gene and 89% identical to the fur A gene of M 
tuberculosis. The region of M ulcerans homologous to the already characterized M 
marinum fur A gene was cloned; and, the construct was used in complementation studies 
in an attempt to confirm the role of Fur A in mycolactone production. Transformation of 
the 1615 :tnp6w mutant with the construct containing fur A failed to restore mycolactone 
production. The failure of the complementation of the fur A gene to restore mycolactone 
production was explained via PCR studies which revealed a spontaneous deletion in the 
thioesterase II gene recently identified to be required for mycolactone production. 
Secondly, experiments aimed at developing an efficient transformation protocol for M 
ulcerans were undertaken. In an effort to determine the effect of temperature on the 
transformation efficiency of M ulcerans via electroporation, electroporation experiments 
were performed on M ulcerans 1615 grown in Middlebrook 7H9 with 10% oleic acid­
albumin-dextrose-complex supplement (M7H9 + OADC). Log phase cultures were 
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harvested, washed with 10% glycerol, and apportioned into 60 µL aliquots. Aliquots 
were briefly held at room temperature, 37t, 40t, or 45t before electroporation in the 
presence of 1 µg of pPR27Hl, a hygromycin B resistance conveying plasmid. After 8 
weeks, colonies were counted to calculate transformation efficiencies. To determine if 
the presence of mycolactone affects electroporation efficiency, this experiment was 
repeated with M ulcerans grown in Modified Reid's synthetic medium and M ulcerans 
grown in Sauton' s synthetic medium, both media which are thought to promote a 
decreased production of mycolactone; M ulcerans grown in Middlebrook 7H9 with 20% 
oleic acid-albumin-dextrose-complex supplement (M7H9 + 2[OADC]), which is believed 
to foster an increased production of mycolactone; and, a polyketide synthase (PKS) 
knock-out mutant of M ulcerans (mutant 115) which does not produce mycolactone 
grown in M7H9 + OADC. Though electroporation of M ulcerans grown in M7H9 + 
OADC produced transformants reliably (regardless of the temperature of the cell at the 
time of electroporation); the transformation efficiencies were not high and, there was no 
significant difference in the transformation efficiencies obtained by cells exposed to 
different temperatures before electroporation. However, an additional experiment, 
demonstrated that these cells exposed to 55t for the same amount of time prior to 
electroporation did have a modest but significant increase in transformation efficiency. A 
similar increase in transformation efficiency was obtained when M ulcerans grown in 
M7H9 + 2[OADC] was electroporated after incubation at the lower temperature of 45t. 
In an additional experiment, the fast growing M fortuitum grown in M7H9 + OADC had 
the highest transformation efficiency when electroporated after incubation at 45t. 
Finally, though the natural reservoir of M ulcerans is unknown, Buruli ulcer disease 
lV 
seems to be associated with water. For this reason, experiments aimed at investigating 
aquatic snails, also associated with water in Buruli ulcer endemic regions, as a 
component of the ecological niche of M ulcerans were undertaken. Snails of the species 
Biomphalaria glabrata are intermediate hosts of the schistosome species Schistosoma 
mansoni; and, it is feasible that M ulcerans could associate with cercariae, the 
schistosomal life stage infectious to humans, infecting humans through the wound caused 
by the cercaria entering its human host. Through various experiments, both healthy 
Biomphalaria glabrata and Schistosoma mansoni-infected Biomphalaria glabrata were 
exposed to M ulcerans and examined for M ulcerans infection via PCR and plating of 
ground tissue. While PCR analysis demonstrated a possible association between M 
ulcerans and healthy snails; M ulcerans was not recovered by plating of the tissue of 
snails exposed to the bacteria during any of three infection experiments. Hystological 
sectioning of snail tissue yielded no reliable data. 
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I. Literature Review 
Clinical Presentation of Buruli Ulcer Disease 
Mycobacterium ulcerans is the causative agent of the necrotizing skin disease 
Buruli ulcer, the third most common mycobacterial disease of non-immunocompromised 
people (81 ). For reasons not fully understood, Buruli ulcer can present in ways unique to 
different endemic regions. In Africa, the disease usually begins as a small subcutaneous 
mobile nodule measuring 1-2 cm in diameter (19, 31). In Australia, the disease most 
commonly begins as an intradermal papule but may also be first noticed as an edematous 
limb, a characteristic of necrotizing panniculitis (31, 3 5). Other pre ulcerative lesions 
that may present include more localized edema and plaques-irregularly shaped 
indurated patches of skin (81 ). These nonulcerative stages of the disease are generally 
painless; however, though not common, they may itch (19). Subcutaneous calcification 
may also occur (12, 31, 76). The first (nonulcerative) stage of Buruli ulcer may persist 
for 1 or 2 months, after which the ulcer characteristic of this disease begins to form, 
extending 15 cm or more (19) (Figure 1). 
After the second (ulcerative) stage of the disease ensues, necrosis of the 
subcutaneous fat along with vascular damage causes the skin overlying the ulcerative 
area to die and slough off, producing secondary ulceration of the skin with a distinct 
undermined edge (81) (Figure 2). If untreated, the ulceration may progress to involve an 
entire limb or up to 15% of the body surface (23). Though rare, extensive ulceration can 
result in osteomyelitis and even autoamputation. Ulcers that begin to heal contain 
granulomatous tissue at their edges and may be said to have progressed to stage 3 of the 
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Figure 1. The progression of the Buruli ulcer lesion to the ulcerative stage. 
(Adapted from van der Werff, et al., 1999.) 
2 
Figure 2. Ulcerative lesion of Buruli ulcer (stage 2) on an arm, leg, and hand. 
(Adapted from Buruli ulcer: Diagnosis of Mycobacterium ulcerans Disease, WHO 
2001.) 
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disease; while, those who have been debilitated by the disease even after the disease has 
healed may be said to be in stage 4 of the disease (70). Though it is thought that massive 
ulcers may cause systemic effects, ordinarily there are no effects beyond the region of the 
ulcer (19). It is rare that Buruli ulcer causes pain or occurs in more than one site on the 
body. Some ulcers may heal spontaneously, doing so slowly over months or years. 
There is anecdotal evidence that patients with such spontaneously healing ulcers develop 
a positive tuberculin skin test; while, those with ulcers which do not spontaneously heal 
remain negative with regard to the tuberculin skin test (81). However, upon 
histopathological examination, there appears to be a lack of a host inflammatory response 
or granuloma formation at the site of the ulcer (12, 33, 76). Unlike other mycobacteria, 
M ulcerans is rarely found inside macrophages. M ulcerans can be found in the ulcer 
only in extracellular foci from which the necrosis extends well into areas from which 
bacteria can not be isolated. 
One study has shown that of the Buruli ulcer patients treated at hospitals, up to 
10% require amputation of a limb ( 6). Common sequelae include ankylosis, contracture, 
and lymphadema, all the result of massive scaring during the healing process (Figure 3). 
The loss of important structures on the face ( e.g., the eye), genitalia, and breasts may also 
occur as a result of the disease or may be required to treat it successfully. People who 
recover from Buruli ulcer are often left with permanent disabilities and unable to care for 
themselves. This is particularly devastating for people who live in regions of the world 
where life is difficult for even healthy individuals. 
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Figure 3. Contracture in an arm and leg after healing of Buruli ulcer. 
(Adapted from Buruli ulcer: Diagnosis of Mycobacterium ulcerans Disease, 
WHO 2001.) 
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Treatment 
The most effective treatment for Bundi ulcer is surgical excision. Excision of the 
early, non-ulcerative stages of the disease is usually curative (76). Because such medical 
care is not readily available for many victims of Buruli ulcer, many do not seek medical 
care until after the disease has progressed to a large, disfiguring ulcer. For the ulcerative 
forms of the disease, surgical excision of the ulcer and a margin of healthy tissue 
followed by skin gr�ing is relatively effective; though, some reports indicate that the 
disease recurs, requiring further surgery, in more than 15% of cases (76). 
Although many drugs such as dapsone, streptomycin, clarithromycin, clofazimine, 
and rifampicin are effective against M ulcerans in vitro, none have been found to be 
effective in vivo on patients with Buruli ulcer disease (76). Studies which have shown 
drugs, such as clofazimine, which are greatly effective in vitro to have no clinical value 
for the treatment ofBuruli ulcer, suggest that drugs taken systemically may be of no 
benefit due to the nature of the lesion, particularly the poor perfusion to it (67, 76). The 
anti-convulsant phenytoin, applied topically, has been reported to promote healing of the 
ulcerative form of the disease with a reduction in scarring and contractures, but results 
have not been substantiated (3). 
Several reports have shown treating Buruli ulcer with heat to be a promising 
treatment (25, 52). This takes advantage of the fact that M ulcerans is heat sensitive. 
However, this method of treatment is not widely utilized and has not been extensively 
evaluated. To be effective, the heat must be applied constantly and requires equipment, 
such as an electric heating pad or other source with thermostatic control, which is not 
readily available in many regions in which Buruli ulcer is endemic. This type of 
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treatment confines patients who are otherwise healthy for long periods of time and is 
most likely not suitable for lesions on the face and other body parts. 
Geographical Distribution and Epidemiology of Buruli Ulcer 
It is believed by many that Buruli ulcer disease was described as early as 1897 by 
Sir Albert Cook in his Mengo Hospital Notes which describe the characteristic ulcers 
among his patients in Kampala, Uganda (1, 13, 76). Aslop, an Australian surgeon, also 
described treating patients with similar ulcers as early as 1937 (5). However, it was not 
until 1948 that Mccallum and colleagues described the ulcers in correlation with their 
causative agent, which they tentatively named the Baimsdale bacillus after the Baimsdale 
region of Australia in which most of their patients with this disease lived ( 48). This 
bacterium was later named Mycobacterium ulcerans; however, the disease is still known 
as Baimsdale ulcer in Australia (82). Though it bares various monikers in different 
regions of the world-for example, Kumusi ulcer in Papua New Guinea, Kasongo ulcer 
in Zaire, and Baimsdale ulcer in Australia, the necrotic lesions caused by M ulcerans are 
most widely known as Buruli ulcer after the Buruli region of Uganda (2, 11, 3 8). This 
region was the site of several large outbreaks of Buruli ulcer in the 1960's and 1970's 
which provided the arena for a more thorough investigation and publication of the disease 
(11, 16). 
In addition to Uganda and Australia, Buruli ulcer has been found endemic to the 
Democratic Republic of Congo, Nigeria, Cameroon, Ghana, Papua New Guinea, 
Malaysia, French Guiana, Mexico, Bolivia, Sri Lanka, Sumatra, and others totaling over 
30 countries (4, 8, 29, 32, 34, 41, 51, 63, 85) (Figure 4). It is interesting to note that 
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Figure 4. Countries in which Buruli ulcer disease has been reported. 
Countries shown in black are regions of endemicity. (Adapted from WHO Bunili ulcer 
website: http://www.who.int/gtb- buruli/ global_ situation/index.html.) 
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based on the broad distribution of the endemic areas of Buruli ulcer, it has been suggested 
that M ulcerans evolved before or during the Jurassic period-before the breakup of the 
continents (32). Though Buruli ulcer disease has been found in non-tropical regions 
such as southern Australia, Japan, and the People' s  Republic of China, it is most 
prevalent in tropical regions (20, 33, 79, 80). While the disease has probably always 
been most prevalent in the rural communities of equatorial Africa, there seems to have 
been a great increase in the occurrence of Buruli ulcer in East Africa in the early 1 970's 
and late 1 960's (2, 41 ). At present, in West Africa a similar epidemic is transpiring, 
contributing to the momentously increasing overall incidence of Buruli ulcer disease ( 4 1 ,  
43, 50, 54). Buruli ulcer was recognized as an emerging infectious disease in 1 998 with 
the establishment of the Global Buruli Ulcer Initiative by the World Health Organization 
(WHO) (85). 
Within the many regions and countries of endemicity, Buruli ulcer disease occurs 
in well defined areas, often called foci, which can be as small as 2 square kilometers in 
size ( 4 1 ,  42, 82). These foci are typically in close proximity to standing or slow moving 
water (e.g., a lake, stream, or swampy area) (4 1 ,  64). For this reason, it is believed that 
the organism is in some way associated with the water or colonizes some organism 
associated with the water. While many different organisms have been experimentally 
infected with M ulcer ans, until recently, the only organisms found to acquire natural M 
ulcerans infections were koalas, ringtail possums, and an alpaca (1 9). In 1 999, Portaels, 
et al . ,  reported the finding of five water bugs from the families Naucoridae and 
Belostomatidae collected in Buruli ulcer-endemic regions of Benin and Ghana to be 
PCR-positive for M ulcerans (65). Recently, the aquatic, carnivorous insects of the 
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family Naucoridae were found able to be experimentally infected with M ulcerans as a 
carrier and transmit this infection to mice upon biting them ( 49). The group conducting 
these studies was then able to isolate M ulcerans from species of this family of insects 
collected from the wild ( 49). Based on this information, it is likely that insects in the 
family Naucoridae do play a role in the transmission of M ulcerans. It is not clear how 
important this role is and what other organisms and environmental factors may be 
involved in the natural reservoir of M ulcerans. 
There have been very few reports of people acquiring Buruli ulcer from those 
already infected. The two most common incidences were infection after a human bite 
and the infection of a plastic surgeon who had excised a Buruli ulcer lesion 
(15, 18). These are considered isolated and possibly unsubstantiated incidences. Buruli 
ulcer is not passed from person to person, and infects people of all ages-both male and 
female. However, it does occur more often in children (17). There appears to be no link 
between the human immunodeficiency virus (HIV) epidemic in Africa and the incidence 
of Buruli ulcer disease; and, co-infection with HIV does not appear to alter the course of 
an M ulcerans infection ( 17). 
Diagnosis of Buruli Ulcer and Identification of Mycobacterium ulcerans 
In regions in which Buruli ulcer is endemic, it is readily diagnosed in the 
ulcerative form. A painless ulcer with undermined edges in the absence of the 
lymphadenitis, fever, or other inflammation present in infections caused by other bacteria 
is unique to the disease caused by M ulcerans. Because the lesions are usually found on 
the limbs or trunk, the ones which appear on the face may be mistaken for cancrum oris, 
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or noma, a disease characterized by necrotic facial lesions which unlike M ulcerans 
exhibit signs of inflammation (81 ). Commonly, acid-fast staining is performed on 
suspected Buruli ulcers; however, neither the presence nor absence of acid-fast bacilli in 
the ulcer can definitively confirm or refute a preliminary diagnosis of Buruli ulcer. In 
most cases the organism can be cultured from the lesion, but culturing requires that the 
appropriate media and incubation apparatus be available and may take three or more 
months ( 48). 
Though generally limited to research and clinical use in industrialized countries, 
PCR can be used to definitively identify M ulcerans. The M ulcerans genome contains 
two insertion sequences, IS2404 and IS2606, which have not been found together in any 
other organism. IS2606 has been found to be present in the genome in up to 40 copies; 
while, IS2404 has been found to be present within the genome in over 50 copies (72). 
IS2606 has been detected in only one other species-M lentiflavum; while, IS2404 to 
date has been detected only in M ulcerans (72). Concurrent detection of both IS2606 
and IS2404 in a single isolate is indicative of M ulcerans. 
Mycolactone 
Due to the presence of only small foci of M ulcerans in even large ulcers it was 
suggested as early as 1965 that Buruli ulcer disease was mediated by a diffusible toxin 
(12). Several studies have demonstrated that the sterile filtrates of M ulcerans have a 
cytopathic effect on L929 murine fibroblasts, causing rounding and detaching from the 
monolayer (22, 36, 46). In 1998, George, et al. was able to partially purify the toxin 
causing this effect and identify the mechanism by which it functions (22). They 
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demonstrated with flow cytometric analysis that the toxin causes cell cycle arrest in the 
G0/G 1 phase of the growth cycle accompanied by cytoskeletal rearrangement (22). One 
year later, the toxin was completely purified, and its structure was determined to be that 
of a 12-membered lactone ring to which two different polyketides were attached (23). 
This molecule, designated mycolactone, as a polyketide-derived macrolide is a member 
of a class of molecules which are often biologically active. This is the first such 
molecule identified' in mycobacteria and any human pathogen. When the biologically 
active molecule, designated mycolactone, was subjected to 1H and 13C NMR, it was 
revealed that the compound actually exists as a mixture of two cis/trans isomers in 
equilibrium at approximately a 3 :2 ratio (21 ). The predominant molecule has been 
designated mycolactone A (Figure 5). Mycolactone A/B is represented by a single peak 
at m/z 765.5 upon mass spectroscopic analysis. It has been found that M ulcerans 
produces not just two isomers of mycolactone, but multiple heterogeneous congeners 
which primarily differ in their number of double bonds and hydroxyl groups (9). In 
2003, Mve-Obiang, et al. reported that while mycolactone A/B was originally isolated 
from M ulcerans 1615, a Malaysian isolate; it has been found in all cytotoxic strains of 
M ulcerans tested except two isolates from Mexico (56). They further reported that a 
mycolactone C, represented by a peak at mlz 726.3 upon mass spectroscopic analysis, 
was the predominant mycolactone in eight Australian strains analyzed; while, a 
mycolactone D (m/z 781.2) was present in two Asian strains of M ulcerans (56). 
Though the congeners have the same biological activity, they differ in potency (56). The 
fact that strains of M ulcerans of the same geographic region appear to produce the same 
repertoire of mycolactones may explain the variation in presentation and severity of 
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Figure 5. Structure of 1) mycolactone A and 2) mycolactone B. 
(Adapted from Gunawardana, et al., 1999.) 
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Buruli ulcer among these different regions. 
14 
II. Materials and Methods 
Bacterial Culture 
Mycobacterium ulcerans 1615, originally isolated from a human patient in 
Malaysia, is a part of the Trudeau Mycobacterial Culture Collection {TMC) and was 
obtained from the American Type Culture Collection (ATCC 35840) (Manassas, 
Virginia). Mycolactone-negative mutants of M ulcerans 1615 not constructed as a part 
of this work, mutants 97 and 115, were obtained from Dr. Armand Mve-Obiang and were 
constructed by him via transposon mutagenesis via a phage delivery system while 
working at the University of Tennessee in Knoxville. All M ulcerans cultures were 
grown in stir flasks at 32t in Middlebrook 7H9 broth (M7H9) (Difeo, Detroit, Michigan) 
with 10% oleic acid-albumin-dextrose-complex (OADC) unless otherwise stated. OADC 
was prepared with bovine serum albumin (BSA) from Sigma (Saint Louis, Missouri) and 
all other reagents from Fisher Scientific (Pittsburgh, Pennsylvania). Both Reid's 
synthetic medium and Sauton's synthetic medium were prepared as described in The 
Mycobacteria: A Sourcebook Part A using reagents purchased from Fisher Scientific 
(84 ). The M fortuitum strain used, M fortuitum fortuitum da Costa Cruz, is a Spanish 
isolate and was obtained from ATCC (ATCC 6841) and is a part of the TMC. It was 
grown in M7H9 with 10% OADC (M7H9 + OADC) while shaking at 37C. 
Transposon Mutagenesis 
Transposon mutagenesis was performed using the commercially available 
EZ::TNTM <KAN-2>Tnp Transposome TM Kit from Epicentre (Madison, Wisconsin). The 
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transposome is constructed by mixing the transposon, a segment of linear DNA 
containing the kanamycin resistance gene Tn903 flanked by 19 bp transposase 
recognition sequences, and the transposase in the absence of magnesium (Figure 6). This 
transposome construct was introduced into M ulcerans through electroporation as 
described below. Upon entry into the cell, the transposome complex is activated by Mg2+ 
present in the cell, and the transposon randomly inserts into the genomic DNA of the 
host. Insertion mutants were selected on Middlebrook 7Hl O agar (Difeo) supplemented 
with 10% OADC (M7Hl0 + OADC) with kanamycin at a concentration of 30 µg/mL, 
because the transposon includes the Tn903 selectable marker, conveying kanamycin 
resistance (Figure 7). 
Electroporation of M. ulcerans 
Electrocompetent cells were prepared in the following manner. All steps were 
carried out in and all reagents were used at room temperature unless otherwise stated. 
Log-phase cultures were harvested by centrifugation at 5,509 x g for 10 min without 
brake. The supernatant was carefully discarded, and the pellet was gradually resuspended 
in a volume of 10% glycerol (Fischer Scientific) equal to one half the volume of the 
original cultur_e. The cells were centrifuged as above, and the pellet was gradually 
resuspended in a volume of 10% glycerol equal to one fifth the volume of the original 
culture. The cells were again centrifuged as above, and the supernatant was carefully 
discarded. The cells were finally resuspended in a volume of 10% glycerol equal to one 
one thousandth the volume of the original culture. The cells were then aliquoted in 60 µL 
volumes into sterile 1.5 mL microcentrifuge tubes. Because mycobacteria have 
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Figure 6. Formation of the EZ: :TNTM Transposome™. 
The EZ::rn™ Transposome ™ is formed by incubating the EZ::rn™ Transposon™ with 
EZ::rn™ Transposase™ in the absence ofMg2+. (Adapted from 2003 Epicentre 
catalogue.) 
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Figure 7. Activation of the EZ: :TNTM Transposome™. 
Upon electroporation into electrocompetent cells, the transposome is activated by cellular 
Mg2+; and, the transposon is randomly inserted into the host genomic DNA. Cells in 
which insertion has occurred are selected for on selective media. (Adapted from 2003 
Epicentre catalogue.) 
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extremely low transformation efficiencies when compared to other bacteria and 
transformation efficiencies of competent cells decrease after storage, electrocompetent 
cells were used immediately. 
Immediately before electroporation, the 60 µL volume of electrocompetent cells 
was loaded into a BT:x® 2 mm gap cuvette (Fisher Scientific) along with 1 µL of DNA 
(at a concentration of 1 µg/µL unless otherwise stated). The cuvette was placed in the 
electroporation ch�ber and pulsed with a Bio-Rad Gene Pulser® II with the following 
parameters: 2.5 kV voltage, 25 µF capacitance, and 800 n resistance. Immediately after 
electroporation, the content of the cuvette was transferred to 2 mL of warm M7H9 + 
OADC, unless otherwise stated, and placed at 32t in a rollerdrum for 72 hours. The 
cells were then plated on M7H10  + OADC plates, unless otherwise stated, with the 
appropriate antibiotic added. The plates were double wrapped in Parafilm M® (Pechiney 
Plastic Packaging, Chicago, Illinois) to prevent dehydration and incubated at 32t. Plates 
were checked weekly. 
Electroporation of M. fortuitum 
Electrocompetent cells were harvested, washed, aliquoted, and electroporated as 
described for M ulcerans. Immediately after electroporation, cells were transferred to 2 
mL M7H9 + OADC and shaken at 37t for 5 hours before being plated on M7H10 + 
OADC with 30 µg/mL aparamycin. Plates were incubated at 37C and checked daily. 
1 8  
To confirm the presence of a transposon insertion in kanamycin resistant colonies 
after transposon mutagenesis, a 1 ,  108 bp fragment of the transposon was amplified with 
primers Tnpl (5' -CTC AAA ATC TCT OAT OTT ACA TTG C-3' ) and Tnp2 (5' -GGT 
TOA TOA GAG CTI TOT TOT AGO T-3' ). To confirm the presence of M ulcerans, a 
492 bp fragment of 1S2404, an insertion element unique to M ulcerans, was amplified as 
described by T. Stinear, et al. with primers MU5 (5' -AOC GAC CCC AGT GOA TTG 
GT-3') and MU6 (5' -CGG TOA TCA AOC OTT CAC GA-3') (72). A small portion of 
each colony to be tested was placed in 200 µL of sterile water and boiled for 20 minutes. 
The bacterial cells were removed by centrifugation. Each 50 µL reaction contained 10 
µL of the boil as template, 250 pmol of each primer, 2.5 units of enzyme mix from the 
FailSafe™ PCR Kit (Epicentre), and 25 µL of2 x FailSafe™ PCR enzyme Buffer B which 
contains dNTPs. As positive controls for the presense of the transposon or 1S2404, a 
reaction was prepared with a template of either 1 ng of the transposome in 10  µL of 
sterile water or 200 ng of M ulcerans genomic DNA 10 µL of sterile water, respectively. 
For the detection of M ulcerans associated with snails, 10 µL of total genomic DNA 
isolated from snail tissue was used as template. The reactions were carried out in a 
thermocycler (Eppendorf, Hamburg, Germany) with an initial denaturation period of 5 
minutes at 94t followed by 30 cycles of 1 )  94t for 1 minute, 2) 55t for 1 .5 minutes, and 
3) 72t for 1 .5 minutes followed by a final elongation period of 10 minutes at 72t. 
To obtain the sequences of the genomic DNA flanking the transposon of M 
ulcerans 16 15  :tnp6w (i.e., to determine which gene was interrupted to give the 
mycolactone-negative phenotype), an arbitrarily primed PCR method was performed. 
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The protocol was obtained from Dr. Eric Rubin at Harvard School of Public Health 
(Boston, Massachusetts) in whose lab the protocol had been adapted from an original 
protocol by O'Toole (59). A separate first round PCR reaction was prepared for each 
side of the transposon. For this reaction, 50 µL reactions were prepared with 1 µL 
mutant 1615:tnp6w genomic DNA as template, 1 unit of Taq DNA polymerase, 1 mM 
dNTPs, 1.5 mM MgCh, 1 mM of ARBl random primer (5'-GGC CAC GCG TCG ACT 
AGT NNN NNN NNN GAG GG-3'), and 1 mM of either ARBlTNPl (5'-GCG GCT 
TTG TTG AAT AAA TCG A-3') to amplify genomic DNA downstream of the 
transposon or ARB1TNP2 (5'-TCC ATG TTG GAA TTT AAT CGC G-3') to amplify 
genomic DNA upstream of the transposon. Both ARB 1 TNP 1 and ARB 1 TNP2 are 
complementary to regions on either side of the transposon approximately 150 bp within 
the transposon. The reactions were carried out in a thermocycler with an initial 
denaturation period of 3 minutes at 95t followed by 10 cycles of 1) 95t for 30 seconds, 
2) 35t for 30 seconds, and 3) 72t for 1.5 minutes followed by an additional 30 cycles of 
1) 95t for 30 seconds, 2) 50t for 30 seconds, and 3) 72t for 2 minutes plus 5 seconds 
per cycle followed by a final elongation period of 7 minutes at 72t. 
For the second round of the arbitrary primed PCR protocol, 50 µL reactions were 
prepared using 1 µL of the first round products as template, 1 unit of Taq DNA 
polymerase, 1 mM dNTPs, 1.5 mM MgCh, 1 mM of ARB2 arbitrary primer ( 5 '-GGC 
CAC GCG TCG ACT AGT AC-3') and 1 mM of either ARB2TNP1 (5' -AGT TGA 
AGG ATC AGA TCA CGC-3') or ARB2TNP2 (5'-TTC CCG TTG AAT ATG GCT 
CAT AAC-3 '). Both ARB2TNP1 and ARB2TNP2 are complementary to regions on 
either side of the transposon between the first round primers complementary to the 
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transposon (ARB 1 TNP 1 and ARB 1 TNP2) and the primers to be used for sequencing. 
The reactions were carried out in a thermocycler with an initial denaturation period of 3 
minutes at 95t followed by 30 cycles of 1) 95t for 30 seconds, 2) 62t for 30 seconds, 
and 3) 72t for 1 minute plus 5 seconds per cycle followed by a final elongation period of 
7 minutes at 72t. The products were sequenced using the sequencing primers included 
in the EZ: :TNTM <KAN-2>Tnp Transposome™ Kit by the University of Tennessee 
Molecular Biology Sequencing Facility (Knoxville, Tennessee). 
To confirm transformation with pPR27HI and pPRFURA, an 822 bp fragment of 
the hygromycin phosphotransferase gene (hph) which conveys hygromycin resistance 
was amplified using the primers HPHl (5'-CGA TGT AGG AGG GCG TGG ATA-3') 
and HPH2 (5'-GCT TCT GCG GGC GAT TTG TGT-3'). To confirm transformation 
with pYUBl 78, a 476 bp fragment of the aparamycin resistance gene (aac(3)-1Va) 
contained on it was amplified using the primers APRAl (5'-GTC CAC AGC TCC TTC 
CGT AGC-3') and APRA2 (5'-CTC GAG ATA ATC GAC GCG TAC C-3'). A small 
portion of each colony to be tested was placed in 200 µL of sterile water and boiled for 
20 minutes. The bacterial cells were removed by centrifugation. Each 50 µL reaction 
contained 10 µL of the boil as template, lmM of each primer, 1 unit of Taq DNA 
polymerase, 1 mM dNTPs, and 1.5 mM MgCh. For positive controls, a reaction was 
prepared with a template of 100 ng of the respective plasmid in 10 µL of sterile water. 
The reactions were carried out in a thermocycler with an initial denaturation period of 5 
minutes at 94t followed by 30 cycles of 1) 94t for 1 minute, 2) 55t for 1 minute, and 3) 
72t for 1 minutes followed by a final elongation period of 10 minutes at 72t. 
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Cytopathicity Assay 
L929 murine fibroblast cells were obtained from ATCC (ATCC CCLI)  and were 
maintained by passaging in Dulbecco modified Eagle medium (DMEM) supplemented 
with 5% heat-inactivated calf serum (Gibco BRL, Grand Island, New York) at 37t with 
5% carbon dioxide. To initially determine if the six insertion mutants obtained via 
transposon mutagenesis were cytopathic, a qualitative cytopathicity assay was performed. 
For this assay, the cells were plated at 6 x 104 cells/well ( after dilution to 6 x 1 04 
cells/mL using a hemocytometer) in a 24-well tissue culture plate and allowed to form a 
confluent mono layer for 24 hours. At this time, 50 µL of sterile filtrate of each of the 
mutants was added to a well. Sterile filtrate was obtained by passing 1 mL of culture 
through a Steritop™ 0.22 µm pore filter (Millipore, Billerica, Massachusetts). After 24 
and 48 hours, the cells in each well were observed for rounding and detachment, which 
both indicate cytopathicity. 
Mass Spectroscopy 
All mass spectroscopy (MS) analysis was performed by Dr. Richard E. Lee of the 
College of Pharmacy, Department of Pharmaceutical Sciences, University of Tennessee 
Health Science Center (Memphis, Tennessee). 
Isolation of ASLs 
Acetone soluble lipids (ASLs) were extracted as described by George, et al. (22). 
The cells of 250 mL of bacterial culture were harvested by centrifugation at 5 ,509 x g for 
10 min at room temperature without brake as described above for harvesting cells for 
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electroporation. Most of the supernatant was discarded; while, a small amount was used 
to resuspend the pellet for transferring the cells to a preweighed 30 mL glass Corex® tube 
(Fisher Scientific). The cells were then centrifuged at 4,000 x g for 10 min at room 
temperature (Fisher Marathon TM 21 OOOR benchtop centrifuge; Fisher Scientific). The 
supernatant was discarded, and the pellet was dispersed around the walls of the tube with 
a small spatula for faster drying in a vacuum oven (Fisher Isotemp TM vacuum oven model 
280A; Fisher Scientific) at approximately 55t and approximately -15 in.Hg. It took 8-10 
hours for the pellets to dry completely. During this process, the tube was wrapped in foil 
to prevent excess light exposure. For quantitative purposes, the dried cell matter was 
massed (analytical balance model TR-204; Denver Instrument Company, Denver, 
Colorado). Then, 15 mL of chloroform:methanol (2: 1, vol/vol) (Fisher Scientific) was 
added to the pellet and stirred for 2 hours. After this time, the tube was centrifuged at 
4,000 x g at 4t for 15 min to separate the organic layer from the cell debris. Organic 
layer (top layer) was carefully removed by Pasteur pipette to a vial for evaporation under 
nitrogen using a heating module (Pierce Reacti-Therm™ heating module; Rockford, 
Illinois) at approximately 55t. After the chloroform:methanol solvent was completely 
evaporated, the vial was placed on ice; and, 2 mL of ice-cold acetone was added to 
resuspend the ASLs present in the isolated organic fraction (total lipid content of cells). 
This suspension was then transferred to a small pre-weighed vial, and the acetone was 
evaporated off as described for the chloroform:methanol. For quantitative purposes, the 
dry ASLs were massed (Metler Toledo AT20 balance;Metler Toledo, Columbus, Ohio). 
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Analysis of ASLs by TLC 
ASL analysis was performed by thin-layer chromatography (TLC) using silica­
coated aluminum TLC plates (All tech, Deerfield, Illinois) and a solvent system consisting 
of chloroform:methanol:water (90: 10: 1, vol:vol:vol) (Fisher Scientific). After the TLC 
plate was run, it was dried with hot air from a common hair dryer. The TLC plate was 
visualized under ultraviolet light, and all visible bands were noted. For further 
visualization of the 1ASLs, the TLC plate was developed by dipping in a para­
anisaldehyde stain solution, then drying with hot air. The stain was prepared by 
combining the following reagents in the following order: 6 mL glacial acetic acid 
(Mallinckrodt Balcer, Inc., Phillipsburg, New Jersey), 30 mL para-anisaldehyde (Acros 
Organics, a division of Fisher Scientific), 540 mL ice-cold ethanol (Aaper Alcohol And 
Chemical Company, Shelbyville, Kentucky), and 30 mL concentrated sulfuric acid 
(Mallinckrodt Balcer, Inc.). 
Isolation of M. ulcerans Genomic DNA 
The isolation of genomic DNA from M ulcerans is very difficult due to its 
polyketide-enriched cell wall. There is no published reference for a consistently high­
yielding genomic DNA isolation protocol for M ulcerans. The technique used in this 
work was adapted from protocols used to isolate genomic DNA from M tuberculosis and 
other mycobacteria. The cells of 100 mL of log-phase culture were harvested by 
centrifugation at 7,500 x g for 15 min without bralce. The supernatant was decanted; and, 
the pellet was resuspended in 5 mL TE (pH 8.0) (Fisher Scientific) and transferred to a 50 
ml Nalgene™ Oalc Ridge Teflon™ FEP tube (Fisher Scientific). To assist in cell lysis, 0.5 
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mL of a 10 mg/mL solution of lysozyme (Sigma) was then added, and the cells were 
incubated at 3 7t for 1 hour. To further lyse cells, 30 µL of 10% SDS (Fisher Scientific) 
and 700 µL of 20 mg/mL proteinase K (Sigma) were added and incubated at 65C 
overnight. Proteinase K was heat-inactivated at 80C for 10 min, and the cell mixture was 
cooled to room temperature before 30 µL of 4 mg/mL RNaseA (Sigma) was added and 
the mixture incubated at 37C for 45 min. 1 mL of SM NaCl and 800 µL of 10% 
CTAB/0.7M NaCl (Fisher Scientific) was added to the mixture which was then incubated 
at 65" C for 20 min. The mixture was then cooled to room temperature before the 
genomic DNA was extracted. Genomic DNA was extracted by adding 8 mL 
chloroform:isoamyl alcohol (24:1, vol:vol) (Fisher Scientific) and vigorously shaking for 
30 seconds. After phase separation was apparent, the tube was centrifuged at 23,500 x g 
for 20 min at 4C. The aqueous layer was removed and genomic DNA was extracted a 
second time in an identical manner using 8 mL phenol: chloroform: isoamyl alcohol 
(25:24:1, vol:vol:vol) (Sigma). The genomic DNA was then precipitated with 800 µL 
3M sodium acetate (pH 5.2) (Fisher Scientific) and 8 mL isopropanol (Sigma) and 
centrifugation at 23,500 x g for 20 min at 4C. The DNA was washed twice with 8 mL 
70% ice-cold ethanol then allowed to dry. It was resuspended in 0.5 mL water at 65C for 
30 min then overnight at 4C. The DNA was quantitated and analyzed for purity via 
spectrophotometry (Eppendorf Biophotometer; Eppendorf). 
Southern Blot 
Approximately 2 µg of genomic DNA of mutant 1615 :tnp6w was digested 
overnight at 37C in each of three digestions with Sacl, Pvull, and EcoRI (New England 
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Bio labs, Beverly, Massachusetts). Genomic DNA from M ulcerans 1615 and an 
Escherichia coli strain known to have an insertion of the EZ::TN™ <KAN-2>Tnp 
transposon were also digested with EcoRI to be used as a negative and positive control, 
respectively. All digestions along with Hindlll cut A DNA ladder (Promega) and 1 kb 
DNA ladder (Promega) were electrophoresed using a .8% agarose gel prepared with 
ethidium bromide. After electrophoresis, the gel was photographed using UV 
illumination to aid in interpretation of the blot. 
The gel was prepared for the Southern blot as prescribed by the ECL TM Direct 
Nucleic Acid Labelling and Detection Systems kit (Amhersham Pharmacia Biotech, Inc., 
Piscataway, New Jersey). Briefly, the gel was subjected to depurination by agitation for 
10 minutes in a depurination solution of 250 mM HCl (Fisher Scientific). After rinsing 
with distilled water, the gel was subjected to denaturation by agitation for 25 minutes in a 
denaturation solution of 1.5 M NaCl and 0.5 M NaOH (Fisher Scientific). After rinsing 
with distilled water, the gel was subjected to neutralization by agitation for 30 minutes in 
a neutralization solution of 1.5 M NaCl and 0.5 M Tris HCL (Fisher Scientific) at pH 7.5. 
After the initial 30 minute period, the neutralization solution was replaced with fresh 
solution and the gel was agitated in this solution for an additional 15 minutes. The 
capillary blot was constructed in the traditional manner as prescribed by the ECL TM Direct 
Nucleic Acid Labelling and Detection Systems kit using 20 x SSC (0.3 M Na3 citrate and 
3 M  NaCl at pH 7.0 (Fisher Scientific)) as the transfer buffer, Whatman 3 MM paper 
(Whatman, Inc., Clifton, New Jersey) as a wick, and a Hybond-N+ membrane 
(Amersham). 
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After overnight blotting, the blot was removed, rinsed with 6 x SSC, allowed to 
air dry, and baked at 80t for 2 hours. The blot was pre-hybridized for 1 hour at 42t and 
then hybridized with labeled probe under the same conditions overnight. The probe was 
prepared from 100 ng of a 1,108 bp fragment of the transposon amplified with primers 
Tnpl (5' -CTC AAA ATC TCT GAT GTT ACA TTG C-3' )  and Tnp2 (5'-GGT TGA 
TGA GAG CTI TGT TGT AGG T-3'). The probe was labeled as directed with a 
proprietary labeling reagent followed by a glutaraldehyde solution both included in the 
ECL ™ Direct Nucleic Acid Labelling and Detection Systems kit. After hybridization, the 
blot was washed twice for 20 minutes each time at 42t with primary wash buffer (6 M 
urea, 0.4% SOS, and 0.5 x SSC (Fisher Scientific)). It was then washed twice for 5 
minutes each time at room temperature in secondary wash buffer (2 x SSC). The blot 
was drained of secondary wash buffer before being developed for 1 minute with equal 
parts of detection reagents 1 and detection reagents 2 included in the kit. The blot was 
drained, wrapped in plastic film, and placed in a film cassette. The film was exposed for 
several minutes. 
Cultivation of Snails 
Schistosome-infected and uninfected snails of the species Biomphalaria glabrata 
were obtained from Dr. Fred Lewis, Schistosomiasis Laboratory, Biomedical Research 
Institute (BRI) (Rockville, Maryland). Those which were infected had been exposed to 
the miracidiae of Schistosoma mansoni strain NMRI, a Puerto Rican strain, en masse at 
eight miracidiae per snail. 
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The snails were maintained as instructed by Dr. Lewis in shallow translucent 
plastic containers (12 in x 7 in x 4 in) with non-airtight lids made of the same material. 
The containers were filled to a depth of two inches with water (1.5 L) which had been 
filtered using a commercially available water filtration system (Pur® Select Faucet 
Mounted Filtration System; Pur, available at most major retail stores) and then aerated for 
two to three days before use. Such conditioning of the water is necessary to insure that 
the snails do not come in contact with substances such as chlorine and copper which are 
deadly to them. Cercariae release greatly decreases the lifespan of the schistosome 
infected snail. Because a change in light intensity and temperature are stimuli which 
cause cercariae release, snails were maintained at room temperature and in constant light. 
The snails of each container were fed a single segment of carefully washed Romaine 
lettuce with an area of approximately two square inches every day. Any uneaten food 
was removed the following day. The snails were placed in common glass 500 mL 
beakers filled with conditioned water every third day for the snail containers to be 
disinfected, washed, and refilled with conditioned water. Once weekly, groups of snails 
were fed approximately .5 in2 of a snail food supplement. 
Prepared Snail Food Supplement 
The snail food supplement was prepared as follows: 250 mL of water was stirred 
and heated. To this was added 2.5 g wheat germ (ICN Biomedicals, Inc., Aurora, Ohio), 
1.25 g nonfat dried milk (Carnation®, available at most major retail stores), 2.5 g Ward's 
Cereal Grass Media (Ward's, Saint Catharines, Ontario, Canada), 2.5 g fish flakes (Tetra, 
Blacksburg, Virginia), and 2.5 g sodium alginate (Fisher Scientific). After mixing, the 
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mixture was poured into a glass pan and autoclaved for 20 minutes, then cooled 
overnight. After cooling, 2% CaCh was poured on the surface and allowed to sit for 24 
hours. The CaCh was poured off and replaced with sterile water. The supplement was 
stored at 4t. 
Infection of Snails with M. ulcerans 
A group of 6 uninfected snails were placed in a 50 mL conical tube with 25 mL of 
conditioned water to which 2.5 mL of M ulcerans 1615 culture was added. A control 
group of 6 snails was placed in a 50 mL conical tube to which 2.5 mL of sterile M7H9 + 
OADC was added. After 24 hours, all snails had died. They were washed repeatedly 
with sterile water. Each group was then placed in 25 mL of a 10 µg/mL solution of 
amikacin, an antibiotic used to kill extracellular M ulcerans during phagocytosis assays. 
After 36 hours, the snails were rinsed with sterile water, frozen at -80t, and ground over 
dry-ice in a sterile tissue grinder. Approximately 20 mg of tissue was placed in a 
microcentrifuge tube for total genomic DNA extraction. The remaining tissue was 
decontaminated and plated as described below. 
Isolation of Total DNA from Snail Tissue 
The Wizard® Genomic DNA Purification Kit (Promega, Madison, Wisconsin) 
was used to isolate total DNA from 20 mg samples of ground snail tissue. The protocol 
was modified to include boiling at 1 OOt for 20 minutes after the addition of the Nuclei 
Lysis Solution. After which, the sample was allowed to cool to room temperature before 
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continuing with the protocol provided in the kit. All reagents used were included in the 
kit. 
Environmental Infection of Schistosome-Infected Snails with M. ulcerans 
Two groups of 10  schistosome-infected snails each were maintained for 4 weeks 
to allow time for the schistosome infection to develop. 2 mL of M ulcerans 1 6 1 5  culture 
was washed twice by centrifugation (4,000 rpm, 25t, 10  min) and resuspension in sterile 
water to reduce its quantity of mycolactone and remove elements of the M7H9 + OADC 
medium in which it was grown which would be harmful to the snails. The final pellet 
was resuspended in 2 mL of sterile water and added to a 500 mL beaker containing 250 
mL conditioned water and one group of 10 snails. The other group of 10 snails served as 
a control and was held in a 500 mL beaker containing 252 mL conditioned water. Both 
beakers were covered in plastic wrap. After 24 hours, each group of snails was returned 
to its respective container and maintained as usual for 8 weeks. 
Infection of Schistosome-Infected Snails with M. ulcerans through Foodborne 
Inoculation 
Two groups of 10  schistosome-infected snails each were maintained for 4 weeks 
to allow time for the schistosome infection to develop. 2 mL of M ulcerans 1 6 1 5  culture 
was washed twice by centrifugation and resuspension in sterile water as described for the 
environmental infection of snails. The final pellet was resuspended in a very small 
volume of water ( 100 µL) and was injected into 1 g of the prepared snail food 
supplement. This food source is very dense and provided a good matrix for delivery of 
the bacteria to one group of 1 0  snails held in a 500 mL beaker containing 250 mL 
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conditioned water. 1 g of sterile food supplement was given to the control group of 10 
snails held in another 500 mL beaker containing 250 mL conditioned water. Both 
beakers were covered with plastic wrap. After 24 hours, each group of snails was 
returned to their respective containers and maintained as usual for 8 weeks. 
Preservation of Snails 
Snails of both the environmental and food infection studies were checked daily. 
When dead snails were not cannibalized, they were washed with sterile water before 
being frozen to be decontaminated and plated later or before being removed from their 
shells using sterile forceps to be fixed. Snail tissue for slide preparation was preserved by 
immediate emersion in Bouin's fixative (LabChem, Inc., Pittsburgh, Pennsylvania) for 4 
days. The snail was then removed and immersed in the following solutions for 24 hours 
each: sterile water, 10% ethanol, 20% ethanol, 30% ethanol, 50% ethanol, and 70% 
ethanol. 
Preparation of Slides 
Histological sectioning and preparation of slides was performed by Histo-Path of 
America (Millersville, Maryland). Sections were stained alternately by hematoxylin-and­
eosin and acid-fast staining. These two staining procedures were chosen, because 
hematoxy lin-and-eosin staining is the procedure commonly used to stain snail sections; 
while, acid-fast staining is the most commonly used staining procedure for identifying 
mycobacteria. There are several references which are helpful in orienting yourself while 
viewing histological snail sections stained with hematoxylin and eosin. 
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Plating Snail Tissue 
Before plating, snrul tissue was frozen at -80t and ground over dry-ice using a 
sterile tissue grinder. The decontamination protocols used were adapted from procedures 
used to decontaminate mammalian tissue for the isolation of M ulcerans. For the 
decontamination of snails from the preliminary infection, most homogenates had volumes 
of 100-200 µL. To this sample, .5 mL 2 M HCl was added. The sample was vortexed 
and incubated at room temperature for 15 minutes. The tubes were then centrifuged at 
6,000 x g for 15 min and the supernatant decanted. Attempts to neutralize the pellet were 
made by adding 2% NaOH drop-by-drop while monitoring the pH with pH test strips. 
Because this was not a very effective method, a new method was adapted for the 
subsequent infection studies. For the infection of snails with M ulcerans through 1) 
environmental inoculation and 2) foodborne infection, the ground snail tissue along with 
5 mL of sterile water used to wash out the tissue grinder was placed in a 50 mL conical 
tube. To the 5mL volume, an equal volume of 2% NaOH was added. The sample was 
vortexed and incubated at room temperature for 15 minutes. After 15 minutes, the 
samples were centrifuged at 3,000 x g for 1 5  min to collect debris and bacteria as a pellet. 
After centrifugation, the supernatant was decanted and the sediment was resuspended in 1 
mL of sterile water. 1 drop of a 0.4% phenol red powder in 2% NaOH was added to the 
solution. The sample was neutralized using a 2 N HCl solution added drop-by-drop. The 
phenol red indicator allowed visual estimation of neutralization. 100 µL, 50 µL, and the 
remaining sample concentrated to 100 µL were plated on M7H9 + 50 µg/mL 
cycloheximide. Plates were wrapped in parafilm and incubated at 32t for 4 months. 
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III. The Identification of a Mycolactone-Negative Mutant of 
Mycobacterium ulcerans 
Introduction 
Mycobacterium ulcerans causes the third most common mycobacterial infection 
in immunocompetent humans world-wide. This infection causes a condition commonly 
referred to as Buruli ulcer disease, which is characterized by necrotizing skin lesions. 
Buruli ulcer disease is considered by many to be the most important mycobacterial 
infection in West Africa and possibly other parts of the world. Poor health care 
availability and substandard infrastructures in the regions endemic to M ulcerans 
infection make it difficult to determine the true number of people affected by this disease 
or even how the disease is transmitted. At present, the only effective means of combating 
this disease is surgical excision followed by skin grafting, measures which are not readily 
available in endemic regions. Any knowledge that could lead to an effective treatment or 
to the prevention of transmission is greatly needed. 
In 1999, a toxin produced by M ulcerans was isolated and its structure was 
determined to be that of a 12-membered lactone ring to which two polyketide chains are 
attached. This molecule was designated mycolactone and was shown upon injection into 
Guinea pigs to produce ulcers that are nearly identical to those produced by the injection 
of M ulcerans itself (23). This and the absence of ulcer formation in Guinea pigs upon 
injection with a spontaneous mycolactone-free mutant of M ulcerans suggests that 
mycolactone could be solely responsible for the development of Buruli ulcer disease (23). 
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It has been suggested that an antitoxin targeted against mycolactone could be an effective 
treatment for Buruli ulcer disease (78). 
However, the development of an antitoxin or other treatment for Buruli ulcer is 
not the principal motivation for studying mycolactone. As a polyketide-derived 
macrolide, mycolactone is a member of a class of compounds which are often 
biologically active and pharmaceutically useful ( e.g., the antifungal amphotericin B, the 
immunosuppressant rapamycin, the antihypercholesterolemic lovastatin, etc.). Some 
polyketides have even multiple pharmacological activities (44). The polyketide 
antibiotic erythromycin is also a gastrointestinal stimulant; and, the immunosuppressant 
FK506 is also an antifungal (39, 45). Mycolactone itself has been demonstrated to be 
biologically active in that in an animal model it causes cell death and lack of an acute 
inflammatory response, mimicking the appearance of Buruli ulcer (24 ). Mycolactone 
has also been demonstrated to cause arrest of the cell cycle in the Go/01 phase in both 
L929 murine fibroblasts and 1774 murine macrophages (23, 24). Based on these 
properties, it is plausible that mycolactone could be of some pharmaceutical value as an 
antineoplastic agent, antibiotic, immunosuppressant or other drug either as it occurs in 
culture or in a modified state. 
Further studies will be required for either the development of an antitoxin or the 
evaluation of mycolactone as a biologically active compound. Research aimed at these 
and any other findings with regard to mycolactone would be greatly facilitated by the 
ability to produce mycolactone in a fast growing mycobacterium (e.g., M smegmatis or 
M fortuitum ). For these reasons, the identification of the molecular machinery required 
to produce this mycolactone is imperative. Based on structural analysis, it was 
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hypothesized that the biosynthesis of mycolactone requires at least 1 00 kb of DNA 
comprising two polyketide synthase (PKS) genes, an acyl transferase, and a p450 
hydroxylase. The large size of the biosynthetic pathway for mycolactone precluded 
ready cloning but made transposon mutagenesis a possible strategy for identifying these 
genes. 
The purpose of the following experiments was to create a mycolactone-negative 
mutant of M ulcerans through transposon mutagenesis and characterize this mutant with 
the intention of identifying a gene involved in mycolactone production. At the time of 
this study, no defined mutant of M ulcerans had been created, and there was no 
established method for making such mutants. 
Results 
In an effort to identify genes responsible for the production of mycolactone, 
efforts to produce a mycolactone-negative mutant of M ulcerans via transposon 
mutagenesis were undertaken. Many attempts to create insertion mutants of M ulcerans 
using the EZ: :TN'™ <KAN-2>Tnp Transposome™ Kit from Epicentre were made by 
delivering the transposon via electroporation. Electrocompetent cells were prepared by 
washing log-phase cultures (grown in stir flasks at 32t in Middlebrook 7H9 with 1 0% 
oleic acid-albumin-dextrose-complex (M7H9 + OADC)) with successively smaller 
volumes of ice-cold 1 0% glycerol and apportioning the final volume of cells into 60 µL 
aliquots. Each aliquot of cells was electroporated with 1 µL (20 ng/µL) of the 
transposome in a 2 mm gap cuvette with a pulse of parameters 2.5 kV, 25 µF, and 800 n. 
The cells were immediately transferred to M7H9 + 0 ADC and incubated in a rollerdrum 
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for 72 hours; after which, the cells were plated on selective media--M7H9 + OADC with 
10 µg/µL kanamycin-and incubated at 32C. After eight weeks of incubation, eight 
colonies had appeared on various selective plates. Five of these colonies were verified 
via PCR to contain the Tn903 kanamycin resistance gene contained on the transposon 
(Figure 8). 
One of these five colonies (mutant 1615:tnp6w), unlike wild-type M ulcerans 
which is yellow, remained white after several months incubation. Because it was known 
that mycolactone imparts the yellow color to wild-type M ulcerans and spontaneously 
arising mycolactone deficient mutants of M ulcerans are white, it was suspected that this 
white colony was mycolactone-negative. Having the same morphology and growth rate 
as wild-type M ulcerans, it was unlikely that any of the colonies were not M ulcerans; 
however, to verify their identity as such, mutants 1615:tnp6w and 1615:tnp3, an insertion 
mutant with a wild-type phenotype, were subjected to PCR analysis for the presence of 
the insertion element 1S2404 unique to M ulcerans. Both mutants were PCR-positive for 
the presence of 1S2404, confirming them to be M ulcerans (Figure 9). 
Both mutants 1615 :tnp6w and 1615:tnp3, which was used as transposon­
containing, phenotypical normal control, were inoculated into M7H9 + OADC for 
expansion. ASLs were isolated from log-phase cultures via methanol:chloroform 
extraction as described by George, et al. (22). Both are PCR-positive for the presence of 
insertion element 1S2404 unique to M ulcerans. 
ASLs of 1615 :tnp6w were analyzed for the presence of mycolactone via thin­
layer chromatography (TLC) on silica-coated aluminum plates. The AS Ls of both M 
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Figure 8. Mutants 1615:tnpl and 1615:tnp3-6 are PCR-positive for the EZ: :TNrM 
<KAN-2> Top Transposome™. 
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Figure 9. PCR analysis of suspected M. ulcerans transposon insertion 
mutants 1615:tnp6w and 1615:tnp3 for the presence of 1S2404. 
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ulcerans 1 6 1 5  and mutant 16 1 5  :tnp3 were included as controls. Approximately equal 
volumes ( approximately 16  µL) and masses ( approximately 825 µg) of AS Ls were 
loaded on the plate for each of the three samples, and the TLC was run in a 
chloroform:methanol:water (90: 1 0: 1, vol:vol:vol) solvent before being stained with para­
anisaldehyde staining solution. While mycolactone was present in both the ASLs 
isolated from M ulcerans 1 6 1 5  and the mutant 161 5  :tnp3 as a band with a ratio to front 
(Rr) value of approximately 0.23, mycolactone was not present in the ASLs of mutant 
16 1 5 :tnp6w (Figure 10). On an additional TLC analysis (not shown) for which nearly 
twice the mass of ASLs was loaded (more than 1 .5 mg), there was still no mycolactone 
detected in the AS Ls isolated from mutant 16 15  :6w. 
To further characterize the 16 15  :tnp6w mutant, a cytopathicity assay was 
performed on sterile filtrate of the mutant. Sterile filtrate was obtained by passing 1 mL 
of log-phase culture through a .22 µm pore polyethersulfone filter. 50 µL of the sterile 
filtrate was added to a well of a 24-well tissue culture plate containing a confluent 
mono layer of L292 murine fibroblasts plated at 6 x 1 04 cells/well. The sterile filtrates of 
wild-type M ulcerans 1 6 1 5  and mutant 161 5 :tnp3 as well as sterile M7H9 + OADC were 
used as controls. At 24 and 48 hours, the cells were examined for rounding and 
detachment, which are both indicative of cytopathicity. At 48 hours, as expected, unlike 
those exposed to sterile M7H9 + OADC, which remained a healthy confluent monolayer 
of rhomboid shaped cells (Figure 1 1  ), the cells exposed to the sterile filtrate of wild-type 
M ulcerans 1 6 1 5  exhibited a great degree of rounding and detachment (Figure 12). 
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Figure 10. TLC analysis of ASLs isolated from M. ulcerans mutant 
1615:tnp6w. 
While mycolactone is present as a band with an Rr value of approximately .23 in 
the ASLs of M ulcerans 1 6 1 5  and M ulcerans mutant 16 1 5 :tnp3, mycolactone is 
not present in the ASLs of M ulcerans 16 15 :tnp6w. 
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Figure 11. L929 murine fibroblasts after exposure to M7H9 + OADC. 
Picture was taken at 48 hours and 100 x magnification. Cells are phenotypically 
undisturbed. 
Figure 12. L929 murine fibroblasts after exposure to sterile filtrate of M. ulcerans 
1615. 
Picture was taken at 48 hours and 100 x magnification. 
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The sterile filtrate of the mutant 1615 :tnp6w had no apparent cytopathic effect. After 48 
hours, fibroblasts exposed to the sterile filtrate of mutant 1615 :tnp6w appeared identical 
to those exposed only to sterile M7H9 + OADC (Figure 13). The sterile filtrate of mutant 
1615:tnp3 had a cytopathic effect on the fibroblasts identical to that of the wild-type M 
uclerans (Figure 14). 
In order to more definitively determine if mutant 1615 :tnp6w was producing 
mycolactone, its ASLs were subjected to mass spectral analysis. The mass spectrum of 
ASLs of wild-type M ulcerans 1615 have a sharp peak at mlz 765.5, which represents 
mycolactone, and a peak at mlz 445.3, which represents the core lactone (Figure 15). 
There are no comparable peaks present in the mass spectrum of the AS Ls of mutant 
1615:tnp6w (Figure 16). The absence of peaks at m/z 765.5 or at mlz 445.3 is indicative 
that neither mycolactone nor core lactone is produced by this mutant. 
Having established mutant 1615:tnp6w to be negative for mycolactone 
production, efforts to determine the location of the transposon were undertaken. A .8% 
agarose gel for Southern blot was prepared with overnight Sad, Pvull, and EcoRI 
digestions of mutant 16 1 5:tnp6w genomic DNA. As a negative and positive control 
(respectively), EcoRI digestions of genomic DNA from M ulcerans 1615 and an 
Escherichia coli strain known to have an insertion of the EZ::TN™ <KAN-2>Tnp 
transposon were also included. Hindlll cut A DNA ladder and 1 kb DNA ladder were 
included in the gel. The Southern blot was prepared as instructed by the ECL ™ Direct 
Nucleic Acid Labelling and Detection Systems kit to be used to probe and develop the 
blot. The blot was washed, pre-hybridized, and hybridized as instructed by the kit. 100 
ng of a 1, 108 bp region of the transposon was labeled using a proprietary labeling reagent 
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Figure 13. L929 murine fibroblasts after exposure to sterile filtrate of mutant 
1615:tnp6w. 
Picture was taken at 48 hours and 1 00 x magnification. Cells appear phenotypically 
undisturbed. 
Figure 14. L929 murine fibroblasts after exposure to sterile filtrate of mutant 
1615:tnp3. 
Picture was taken at 48 hours and 1 00 x magnification. 
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Figure 15. Mass spectrum of M. ulcerans 1615 ASLs. 
The large, sharp peak at mlz 765.5 is known to represent mycolactone, the most abundant 
species present; while, the peak at mlz 445.3 is known to represent the core lactone. 
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Figure 16. Mass spectrum of M. ulcerans 1615:tnp6w ASLs. 
The absence of a peak at mlz 765.5 indicates that mycolactone is not produced by this 
organism. In addition, there is no peak at mlz 445.3 ,  the peak which is known to 
represent the core lactone. 
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followed by a glutaraldehyde solution as described by the kit and was used to probe the 
blot. The blot was developed chemically using proprietary developing reagents included 
in the kit. Hybridization by the probe was detected by exposing the blot to film for 
several minutes. Single, distinct bands were hybridized by the transposon­
complementary probe for both the genomic mutant 1 6 1 5 :tnp6w genomic DNA digested 
with Pvull and that digested with EcoRI, indicating that the transposon is present in only 
one copy (i .e. , one insertion) in the genome of the mutant (Figure 17). These bands 
migrated from the well 22 mm and 1 1  mm, respectively. There was no clear band 
hybridized to the probe in the lane corresponding to the mutant genomic DNA digested 
with Sad-only a high molecular weight smear. This can be attributed to incomplete 
digestion as was also evidenced by the picture of the gel taken before blotting (not 
shown). As expected, the probe hybridized to a distinct area corresponding to the 
genomic DNA of the E. coli transposon insertion mutant-the positive control-but did 
not hybridize to that of M. ulcerans 1 6 1 5-the negative control. Linear regression 
analysis revealed that the transposon is located in the mutant 16 1 5 :6w genomic DNA on 
a fragment of DNA of approximately 6.5 1 kb in a Pvull digestion and a fragment of 
approximately 1 5 .39 kb in an EcoRI digestion. 
In an effort to determine what gene had been interrupted by the insertion of the 
transposon in the mutant 16 15 :tnp6w, several attempts at sequencing directly from the 
genomic DNA were made. These attempts were unsuccessful. Next, many attempts to 
clone the transposon with its flanking regions of genomic DNA to be sequenced from the 
newly created plasmid were made by both the shotgun method and by attempting to 
isolate and clone only the 6.5 1 kb Pvull fragment of genomic DNA. These also were 
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Figure 17. Film exposed by the Southern blot of mutant 1615:tnp6w genomic DNA 
probed with a probe complementary to a 1.1 kb region of the transposon. 
Digestion of 16 15 :tnp6w genomic DNA with SacI was incomplete. A single band of 
PvuII digested genomic 16 15  :tnp6w DNA of approximately 6.5 kb was hybridized by the 
probe; while, a single band of EcoRl digested genomic 16 15 :tnp6w DNA of 
approximately 1 5.39 kb was hybridized by the probe. EcoRl digested genomic DNA 
from E. coli:tnp, a confirmed transposon insertion mutant, and from wild-type M 
ulcerans 16 15  were used as a positive and negative control, respectively. 
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unsuccessful. 
To obtain sequence data from the regions of genomic DNA flanking the 
transposon, a two part arbitrarily primed PCR technique was employed. The first round 
of PCR utilized a primer 150 bp within the transposon and a random primer containing 
sequences common in mycobacteria. This PCR reaction produced DNA fragments of 
varying lengths, all flanking the transposon (and containing over 100 bp of it). The 
second round of PCR in this arbitrarily primed PCR protocol used the first round 
products as template and an arbitrary (rather than random) primer which was nearly 
identical to the random primer with out the random bases. The second primer used in this 
reaction was a primer complementary to the transposon in a region 50-100 bp within the 
transposon. This amplified many fragments of DNA of the same length flanking the 
tranposon. This concentrated amplification of DNA adjacent to the transposon was 
sequenced using the sequencing primers included in the transposon kit. 
The sequence obtained from the reactions which amplified DNA downstream of 
the transposon was poor; and, when a Blast search was performed, no strong homologies 
were identified. The sequence obtained for the DNA upstream of the transposon, 
however, was 97% identical to the M marinum ferric uptake regulator homolog (FurA) 
gene and 89% identical to the same gene (furA) of M tuberculosis. The arbitrarily 
primed PCR protocol was repeated and the final products sequenced. The sequences 
obtained were identical to the ones previously obtained. At this time, it was uncertain 
where the transposon was inserted in relation to the fur A homologue of M ulcerans. 
Several months after this mutant was found to have an insertion in the fur A 
homologue of M ulcerans, Dr. Armand Mve-Obiang independently identified a second 
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mycolactone-negative mutant (mutant 97) which also has an insertion in the same gene. 
This reinforced the suspicion that the fur A homologue of M ulcerans could be a 
regulator of mycolactone. For complementation studies, the sequence of the M marinum 
fur A homologue was obtained and used to search the Burulist database 
(http://genopole.pasteur.fr/Mulc/BuruList.html}, a database organized by the Pasteur 
Institute to allow access to the unannotated genomic DNA sequences of M ulcerans, for 
the M ulcerans homologue of furA. This database identified thefurA homologue of M 
ulcerans to be on a 7.6242 kb contig designated mu0181G02F PhrapUL 7.6242. The 
entire sequence of this contig was obtained from Dr. Tim Stinear (Pasteur Institute, Paris, 
France) and within it the fur A homologue was identified. At this time, the sequence data 
obtained from the forward and reverse products of the arbitrarily primed PCR protocol 
were pieced together and compared to the sequence of this region available in the contig. 
The transposon insertion of mutant 1615 :tnp6w appeared to be located, not in the actual 
structural gene ofthefurA homologue, but approximately 270 hp upstream of this gene. 
This region of DNA is not homologous to any know prokaryotic genes and could be a 
noncoding region of the M ulcerans genome. 
The sequence obtained from the mu0181G02F PhrapUL 7.6242 contig was used 
to create primers to amplify the fur A homologue of M ulcerans and approximately 500 
hp upstream and downstream of the gene. These primers were used to amplify the 
corresponding region of DNA of wild-type M ulcerans 1615. This region of DNA was 
cloned into the shuttle vector pPR27HI and the construct used to complement the mutant 
1615 :tnp6w and mutant 97. Several transformants were obtained when the mutant 
1615 :tnp6w was electroporated with this construct. (No mutant 97 transformants were 
49 
obtained.) However, after several months incubation, none of the transformants had 
turned yellow. Cytotoxicity assays on L929 murine fibroblasts treated with sterile filtrate 
of the transformants revealed that the transformants did not produce any cytotoxic 
compounds present in the media. 
In search of an explanation for the lack of mycolactone production upon 
complementation of the mutant:tnp6w with thefurA homologue of M ulcerans, this 
mutant was analyzed via PCR for the presence of two genes, one encoding an enoyl 
reductase and the other a thioesterase (11), recently identified to be essential for the 
production of mycolactone. These genes are in areas of genetic instability and are 
thought to be frequently lost due to recombination. While mutant 97 contained both of 
these genes as evidenced by the PCR reaction, the thioesterase was not present in the 
mutant 1615:tnp6w. The mutant 1615:tnp6w had a mycolactone-negative phenotype due 
to the deletion of the thioesterase (11) gene required for mycolactone production, rather 
than the insertion in thefurA homologue. However, the possibility of the FurA 
homologue of M ulcerans playing a role in the regulation of mycolactone production can 
not be eliminated. 
Discussion 
Through many attempts over many months to create mycolactone-negative 
mutants of M ulcerans through transposon mutagenesis, only a total of five PCR­
confirmed insertion mutations arose. This can be contributed to the extremely low 
transformation efficiency of M ulcerans combined with the statistical improbability of 
transposition. While it might seem highly fortuitous to some that a mutant of the 
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phenotype desired--a mycolactone-negative mutant-would be present in a pool of only 
five insertion mutants; constructing a mycolactone-negative mutant of M ulcerans was 
not seen as an endeavor that would require the production of large libraries of mutants. 
At the time of this study, based on the knowledge of other polyketides, it was 
hypothesized that the genetic elements required for the synthesis of mycolactone would 
be comprised of more than 100 kb of DNA and would include two polyketide synthase 
(PKS) genes, an acyl transferase, and a p450 hydroxylase. For this reason, it was not 
surprising that in even a small pool of insertion mutants there appeared to be a mutant 
with an insertion in such a large genetic target. 
The putative mycolactone-negative mutant was recognized as such by its lack of 
pigmentation. Wild-type M ulcerans has a very obvious yellow color which was thought 
to be due to the presence of mycolactone, a compound with the conjugated double bonds 
that cause molecules to be pigmented. Strains of M ulcerans that had spontaneously lost 
pigmentation after repeated culturing in the lab had been found to be mycolactone­
negative. The putative mycolactone-negative insertion mutant remained white after 
many months of growth. All other insertion mutants obtained were yellow and have 
remained so. To rule out the remote possibility that the putative mycolactone-negative 
mutant was not M ulcerans but some contaminant, the mutant was verified by PCR to 
have the IS2404 insertion element, a genetic element unique to M ulcerans. 
The predominant species of mycolactone produced by M ulcerans 1 6 1 5 , the 
strain from which the insertion mutants originated, is know to have an Rr value of 
approximately .23 when analyzed via TLC using the solvent system used in these 
experiments. To analyze the composition of the ASLs of mutant 16 15 :tnp6w and to 
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determine if they contained mycolactone or any molecules of similar size and polarity, 
the ASLs of a log-phase culture were isolated and analyzed via TLC using the ASLs of 
phenotypically normal transposon insertion mutant 1615 :tnp3 and wild-type M ulcerans 
as controls. While the AS Ls of the mutant 1615 :tnp3 contain a band at approximately Rr 
.23 as do the ASLs of M ulcerans 1615 this band or one comparable to it is not present in 
the ASLs of the mutant 1615:tnp6w. 
Though by TLC analysis of ASLs, mutant 1615 :tnp6w appeared to be 
mycolactone-negative, cell cytotoxicity assays were performed on the sterile filtrate of 
this mutant using L929 murine fibroblasts. The sterile filtrates of M ulcerans 1615 and 
mutant 1615:tnp3 were used as positive controls; while, sterile M7H9 + OADC was used 
as a negative control. Mycolactone, which is present in the sterile filtrate of strains that 
produce it, is known to cause cell cycle arrest in fibroblasts by rearrangement of the 
cytoskeleton. In cell culture, this is made apparent by rounding of the cells followed by 
their detachment from the monolayer. This affect, as expected, was seen in cells treated 
with the sterile filtrate of both M ulcerans 1615 and the phenotypically normal mutant 
1615 :tnp3 ; however, the sterile filtrate of mutant 1615 :tnp6w produced no such effect, 
and after 48 hours cells treated with it looked identical to cells treated with sterile M7H9 
+ OADC. Similar assays (not shown) on the ASLs of this mutant 1615 :tnp6w produced 
identical results. It is clear that mutant 1615 :tnp6w is not cytotoxic. 
To definitively prove that this mutant does not produce mycolactone, its ASLs 
were analyzed via mass spectroscopy. The mass spectrum of mutant 1615 :tnp6w did not 
have peaks at either mlz 765.5 or mlz 445.3, which represent mycolactone and its core 
lactone, respectively. It should also be noted that the mass spectrum of the ASLs of this 
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mutant did not have any peaks which represent any of the less common congeners of 
mycolactone. Mutant 1615 :tnp6w is clearly mycolactone-negative as evidenced by this. 
Though the EZ::TN™ <KAN-2>Tnp transposon is designed so that sequence data 
can be obtained by sequencing out from either end of the transposon directly from 
genomic DNA, this was not feasible with M ulcerans. M ulcerans has an extremely 
GC-rich genome, and sequencing directly from the genome is further complicated by the 
inability to isolate high concentrations of clean genomic DNA from this organism. After 
several attempts at obtaining sequence data directly from the genome, new approaches 
were considered. Many attempts at shotgun cloning using various enzymes and vectors 
were unsuccessful. The Southern blot of Pvull and Eco RI digested mutant 1615 :tnp6w 
genomic DNA revealed that when digested with these enzymes, the fragment containing 
the transposon was approximately 6.5 kb and 15.4 kb, respectively. While the 15.4 
EcoRI fragment might be difficult to clone, the smaller 6.5 kb Pvull was thought to be 
readily clonable. Many attempts at digesting mutant 1615:tnp6w genomic DNA with 
Pvull, running the DNA on a gel, excising the bands of DNA corresponding to 
approximately 6.5 kb, extracting the DNA from a gel and ligating the DNA to a Pvull cut 
vector were unsuccessful. It is very difficult to isolate from M ulcerans the large 
quantities of DNA needed for cloning and even more difficult to isolate unsheared, pure 
DNA from this organism. This lack of DNA was exacerbated by the need to purify DNA 
from a gel. Several methods for doing this were tried and compared. All result in the 
loss of a significant percentage of the DNA to be isolated. The inability to to obtain 
sequence data from direct sequencing or from cloning the transposon containing fragment 
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necessitated alternative methods for determining which gene had been interrupted by the 
insertion of the transposon. 
The arbitrarily primed PCR protocol proved to be a very useful tool for 
identifying the gene which had been interrupted by the transposon. With this method, 
sequence data was obtained that suggested that the transposon had inserted into the fur A 
homologue of M ulcerans . Not long after it was determined that the transposon had 
possibly interrupted the fur A homologue of M ulcerans, an independently created 
mycolactone-negative mutant (mutant 97 from Dr. Armand Mve-Obiang) was also found 
to have a single interruption in the same gene. This was the impetus to continue 
characterization of this mutant after discovering that the gene which was interrupted-the 
fur A gene-was most likely not directly involved in the synthesis of mycolactone. 
The FurA protein of M marinum is an orthologue of the E. coli transcription 
factor Fur (ferric uptake regulation). The fur genes of M tuberculosis are thought to be 
transcriptional regulators of genes involved in functions other than acquisition of iron 
(14). In mycobacteria,/urA is ubiquitously linked to the catalase-peroxidase gene katG 
and has been shown to be a negative regulator of katG (60, 86). It is thought thatfurA 
may regulate virulence factors other than katG. 
Complementing the mutant 1615 :tnp6w with thefurA homologue of M ulcerans 
did not result in the production of mycolactone; however, mutant 97 was not able to be 
transformed. Via PCR analysis, the lack of restored mycolactone production in mutant 
1615 :6w has been explained by a deletion in the thioesterase (II) encoding gene which 
has recently been identified as essential for mycolactone production (73). This deletion 
is most likely the cause of the mycolactone-negative phenotype, rather than the insertion 
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of the transposon into the fur A homologue of M ulcerans. Electroporation is associated 
with increased mutation rates and may have caused this deletion in the thioesterase (II). 
It should also be noted thatfurA, possibly functioning as an iron uptake regulator in M 
ulcerans, could protect the cell from damage due to excess iron. It is possible that in a 
FurA-minus mutant, increased levels of iron within the cell would lead to an increased 
mutation rate. The possibility that FurA plays some role in the regulation of mycolactone 
can not be ruled out at this time. 
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IV. Optimization of the Electroporation Efficiency of Mycobacterium 
ulcerans and Mycobacteriumfortuitum 
Introduction 
The development of the electroporation technique--in which electrocompetent 
bacterial cells are subjected to a brief, strong electrical impulse which permeabilizes their 
membranes, allowing them to take-up DNA--was a great advance in the field of genetic 
engineering. The electroporation protocol developed for use with mycobacteria was 
based on the traditional protocols which are generally highly effective when used on 
other genera of bacteria (61). These protocols require that cells are washed and remain 
at 4C at all times to achieve optimal transformation efficiencies (30). Such technique 
has been found comparably effective for the transformation of Mycobacterium smegmatis 
and possibly other fast-growing mycobacteria (40, 61, 83). However, for other strains of 
mycobacteria, transformation efficiencies achieved with these techniques are 
significantly lower. With M ulcerans, these techniques are not effective at all. There are 
no published reports of successful electroporation into M ulcerans; nevertheless, 
electroporation is considered the best method of transformation for any mycobacteria 
( 40). An effective electroporation protocol is greatly needed for M ulcerans. Without 
this tool, prolific complementation studies and studies implementing transposition 
mutagenesis are impossible. 
In 1996, Wards and Collins published a study demonstrating that M bovis cells 
prepared for electroporation at room temperature have a significantly higher 
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transformation efficiency than those washed at the traditional 4t (83). In 2000, Talaat 
and Trucksis, found that the same is true for M marinum (74). In addition, Wards and 
Collins also demonstrated that for M bovis, M tuberculosis, and M intracel/ulare the 
highest electroporation efficiencies are achieved when the cells are electroporated at 3 7t; 
while, for M smegmatis, the highest electroporation efficiencies are achieved when the 
cells are electroporated at the traditional 4t (83). 
The following experiments were performed to determine the effect of the 
temperature of the cell at the time of electroporation on transformation efficiency in M 
ulcerans. The findings of these studies were then tested on the faster growing M 
fortuitum, another atypical mycobacteria for which high transformation efficiency is not 
readily achieved. Studies are also described here which are aimed at determining the 
effect of mycolactone on the electroporation efficiency of M ulcerans. 
Results 
There have been no published accounts of successful transformation into M 
ulcerans. Transformation of M ulcerans at the time this study was begun had been 
achieved, though with minimal success, only by washing cultures of M ulcerans grown 
in Middlebrook 7H9 with 10% oleic acid-albumin-dextrose-complex (M7H9 + OADC) 
with ice-cold 10% glycerol and electroporating the resulting cells at 4t with parameters 
set at 2.5 kV, 800 n, and 25 µF, parameters similar to those used with other 
mycobacteria. Because electroporation at higher resistances has been shown to result in 
higher efficiencies in other species, the number of transformants obtained by 
electroporating three identical aliquots of 10% ice-cold glycerol washed M ulcerans at 
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each of 800 n, 900 n, and 1000 n resistance was compared. For each pulse, capacitance 
and voltage were held constant at 25 µF and 2.5 kV, respectively. All steps were carried 
out at 4t. Immediately after electroporation, cells were transferred to 2 mL of M7H9 + 
OADC and placed in a rollerdrum at 32t. After 72 hours, the cells were plated on 
selective media. None of the nine aliquots resulted in a single transformant. As a result, 
it can not be determined with certainty at which resistance the electroporation efficiency 
of M ulcerans would be highest. However, it is likely that the highest electroporation 
efficiency would occur with electroporations at 800 n resistance. Arcing seemed to 
increase with an increase in resistance. All samples pulsed at 1000 n arced; while, only 
one arced when pulsed at 900 n. None of the samples arced when pulsed at 800 n. 
Arcing is known to greatly decrease electroporation efficiency in other species of 
mycobacteria, because it results in massive cell death. This seems to be true for M 
ulcerans as well. M ulcerans cells plated on non-selective media after an arcing pulse 
took six weeks to grow up ( compared to four weeks for cells subjected to a non-arcing 
pulse) and failed to form a lawn on the plate as was seen on the non-selective media 
plates of a non-arcing pulse. These observations of greatly decreased survival of M 
ulcerans subjected to arcing compared to M ulcerans subjected to a non-arcing pulses 
suggests that the resistance least likely to result in arcing, 800 n, should be used. All 
subsequent electroporation experiments with M ulcerans were carried out with pulses of 
the parameters 2.5 kV, 800 n, and 25 µF. It was determined that it was imperative to 
examine factors other than resistance which may improve electroporation efficiency in M 
ulcerans. 
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The Effect of Temperature on Electroporation Efficiency 
M ulcerans cells had previously been washed at 4t as prescribed by 
protocols for the preparation of electrocompetent cells of nearly all other bacteria; 
however, two studies had been published demonstrating that electroporation efficiencies 
of M bovis and M marinum increase when the cultures are washed at room temperature 
(74, 83). In a preliminary electroporation study to determine if an increase in temperature 
of the M ulcerans cells at the time of electroporation would result in a higher 
transformation efficiency, a method for preparing electrocompetent M ulcerans at room 
temperature was tested. The cells of a 400 mL culture of M ulcerans were harvested and 
washed at room temperature with successively smaller volumes of room temperature 
10% glycerol. The final pellet was resuspended in 2 mL of 10% glycerol and the cells 
were apportioned into 60 µL aliquots. Three aliquots were held at each of three 
temperatures, 1) 4t, 2) room temperature, and 3) 37t, for 10 minutes prior to their 
electroporation with 1 µL ( of a stock at a concentration of .3 µg/µL) of the hygromycin B 
resistance conveying plasmid pPR27HI. No arcing occurred with incubation at any 
temperature with these room temperature washed cells. Immediately after 
electroporation the cells were transferred to 2 mL pre-warmed M7H9 + OADC and 
incubated in a rollerdrum at 32C for 72 hours. After this time, the cells were plated on 
selective media. Though transformants appeared by 6 weeks of incubation, colony 
counts were made at 8 weeks of incubation (Table 1). No transformants resulted from 
cells electroporated after incubation at either 4C or room temperature; however, both 
trials after incubation at 3 7C produced transformants. 
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Table 1. The number of transformants resulting from the electroporation of M. 
ulcerans grown in M7H9 + OADC after incubation at 4t, room temperature, and 
37t after prepara�on at room temperature. 
Temperature 
4c Room 31C 
Temperature 
No 
DNA 0 0 0 
Control 
c... 
0 � 
a. = � = DNA 
.c e I 0 0 76 e • Trial 1 = cS z r,:i - = = = I ,.. a. 0 E--i E--i 
DNA 
0 0 58 Trial 2 
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In a subsequent experiment to further investigate the effect of temperature on 
electroporation efficiency, the cells of a 250 mL culture of M ulcerans 1615 grown in 
M7H9 + OADC were harvested, washed at room temperature with 10% glycerol, and 
aliquoted as described previously. Five aliquots of approximately 5 x 105 cells each ( one 
control and four experimental) were held at room temperature (25t), 37t, 40t, and 45·c 
for ten minutes prior to electroporation with 1 µg ( concentration of 1 µg/µL) of the 
hygromycin B conveying plasmid pPR27HI. After electroporation, the cells were 
incubated at 32t in a rollerdrum for 72 hours before being plated on selective media as 
described previously. Controls plated on non-selective media grew up within four weeks; 
while, many transformants appeared by six weeks. After eight weeks, the transformants 
were counted (Figure 18). Cells electroporated after incubation at 25· C had any average 
of 6 transformants/µg of DNA; while, those electroporated after incubation at 3 7t had an 
average of 23 transformants/µg of DNA-a small but significant increase in 
electroporation efficiency. Cells electroporated after incubation at 40t had an average 
transformation efficiency of approximately 45 transformants/µg of DNA; while, those 
electroporated after incubation at 45t had an average transformation efficiency of 
approximately 39 transformants/µg of DNA. However, due to great variability in the 
number of resulting transformants among aliquots electroporated after incubation at 40C 
and 45t, there was no significant increase in transformation efficiency after incubation at 
either of these temperatures when compared to those electroporated after incubation at 
37t. However, with cells electroporated after incubation at 55t, which had an average 
transformation efficiency of 159 transformants/µg of DNA, there was a significant 
increase in transformation efficiency. There were no spontaneous hygromycin resistant 
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Figure 18. Average number of transformants resulting from electroporations of M. 
ulcerans grown in M7H9 + OADC at each temperature. 
Average was computed from sample size n = 3 .  Error bars represent ± 1 standard 
deviation. 
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mutants arising from any of the cells electroporated after incubation at each temperature 
without pPR27HI; however, the transformants were confirmed via PCR amplification of 
the hph hygromycin resistance gene contained on the plasmid. 
To determine if the trend of increased electroporation efficiency after incubation 
at higher temperatures could be applied to improve the electroporation efficiencies of 
other atypical mycobacteria, this experiment was repeated using M fortuitum grown in 
M7H9 + OADC. M fortuitum is another atypical mycobacterium for which there is no 
published protocol for transformation. M fortuitum, like M ulcerans, has a lipid-rich 
cell wall; however, unlike M ulcerans, it is considered a fast grower, reaching log phase 
in three to four days. This is a particularly attractive characteristic to those who would 
like to express mycolactone (and perhaps other products of slow growing mycobacteria) 
in M fortuitum to decrease the time required for its production; however, M fortuitum 
can not be useful for such purposes until it can be efficiently transformed. M fortuitum 
cells were harvested, washed, and aliquoted as described for M ulcerans ( approximately 
5 x105 cells). The cells were electroporated with 1 µL of DNA (at a concentration of 1 
µg/µL) after incubation for 10 minutes at room temperature (25C), 37t, 40t, and 45°C at 
2.5 kV, 25 µF, and 800 n. After electroporation, cells were transferred to 2 mL M7H9 + 
OADC and shaken for 5 hours at 37t. Because M fortuitum was found to be resistant to 
hygromycin B, the aparamycin resistance conveying plasmid p YUB 185 had to be used 
rather than pPR27HI. Therefore, transformants were selected on M7H9 + OADC with 30 
µg/mL aparamycin and appeared after 5 days of incubation at 3 7t (Figure 19). The 
average number of transformants for cells electroporated after incubation at 4C was 
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Figure 19. Average number of transformants resulting from electroporations of M. 
fortuitum grown in M7H9 + OADC at each temperature. 
Average was computed from sample size n = 3 .  Error bars represent ± 1 standard 
deviation. 
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2 transformants/µg of DNA; while, that for cells electroporated at 25t was approximately 
11 transformants/µg of DNA. A further increase in electroporation efficiency was seen 
with cells electroporated at 37t, which had an average number of transformants of 
approximately 21 transformants/µg of DNA. The electroportation efficiency of cells 
electroporated after incubation at 45t, approximately 1,173 transformants/µg of DNA, 
was greater than ten-fold higher than that of cells electroporated after incubation at 40t, 
106 transformants/µg of DNA. 
The Effect of Mycolactone on Electro po ration Efficiency 
Though the increase in electroporation efficiency of M ulcerans achieved 
by increasing the temperature of the cells at the time of electroporation are a marked 
improvement, efficiencies of 102 transformants/µg of DNA pale in comparison to the 106 
and higher transformants/µg of DNA transformation efficiencies of other bacteria. Other 
methods of improving the electroporation efficiency of M ulcerans need to be explored. 
It is thought that a great hindrance to transformation of M ulcerans is its thick, 
polyketide-enriched cell wall. Because mycolactone is thought to be a major constituent 
of this cell wall, experiments were undertaken to determine the effect of mycolactone on 
electroporation efficiency. Mycolactone has been found to constitute approximately 10-
20% of the total AS Ls produced by a given M ulcerans culture. Previous studies in the 
lab suggested that M ulcerans grown in either Sauton's synthetic medium or Reid's 
synthetic medium produces significantly less ASLs ( and therefore less mycolactone) than 
M ulcerans grown in M7H9 + OADC;while, M ulcerans grown in M7H9 with 20% 
OADC supplement (M7H9 + 2[OADC]) produces significantly more ASLs (and 
therefore mycolactone). To determine the effect of mycolactone on electroporation 
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efficiency, 500 mL cultures of M ulcerans grown in Sauton's synthetic media, Reid's 
synthetic media, M7H9 + OADC, M7H9 + 2[OADC], and of a mycolactone-negative M 
ulcerans PKS knock-out mutant 115 grown in M7H9 + OADC were divided into two 250 
mL portions: one portion to be subjected to the electroporation experiment described 
above aimed at determining the effect of temperature on the electroporation efficiency of 
M ulcerans and acetone soluble lipids (ASLs) to be extracted from the other portion. For 
the electroporation experiment, cells were harvested, washed, and aliquoted as described 
above. Five aliquots ( one control and four experimental) of approximately 5 x 105 cells 
each were held at room temperature (25t), 37t, 40t, and 45t for 10 minutes prior to 
electroporation with 1 µL ( concentration 1 µg/µL) of the hygromycin B resistance 
conveying plasmid pPR27HI with a single pulse of constant parameters (2.5 kV, 25 µF, 
and 800 fl). (M ulcerans grown in M7H9 + OADC was also electroporated after 
incubation at 55t.) Because a previous study ( data not shown) demonstrated that cells 
fromM ulcerans cultures grown in Sauton's or Reid's synthetic medium were more 
likely to recover if transferred to M7H9 + OADC (than the medium in which they were 
grown) and then plated on M7H10  + OADC, cells were transferred to 2 mL M7H9 + 
OADC immediately after electroporation. After 72 hours of incubation in a rollerdrum at 
32C, the cells were plated on selective media. 
In order to isolate ASLs, total lipids were extracted with chloroform:methanol 
(2:1, vol/vol). After drying off the chloroform:methanol under nitrogen, ice-cold acetone 
was added to the desiccated lipids. ASLs were resuspended in the acetone and 
transferred to another vial along with the acetone. The total ASLs extracted were massed 
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(Table 2), and approximately 60 µg of each was analyzed via thin-layer chromatography 
(TLC) (Figure 20). 
Though all non-selective plates contained growth within eight weeks, no 
transformants resulted from the electroporations of cells grown in either Sauton' s or 
Reid's synthetic medium. The number of transformants obtained for M ulcerans grown 
in M7H9 + OADC is shown in Figure 21 and was discussed previously; while, the 
number of transformants obtained for M ulcerans grown in M7H9 + 2[OADC] is shown 
in Figure 21. While M ulcerans cultures grown in Reid's and Sauton's synthetic media 
do produce less mycolactone, they do not produce transformants when electroporated 
after incubation at any temperature. These media are not appropriate for growing 
cultures for transformation. The same was true for the mycolactone-negative PKS 
mutant 115 of M ulcerans. While M ulcerans grown in M7H9 + 2[OADC] does seem 
to produce more mycolactone than M ulcerans grown in M7H9 + [OADC], the number 
of transformants resulting from cells grown in M7H9 + 2[OADC] electroporated after 
incubation at 25t, 3 7t, and 40t is not significantly different from the number of 
transformants resulting from cells grown in M7H9 + [OADC] at those same 
temperatures, respectively. However, the average transformation efficiency of cells 
grown in M7H9 + 2[OADC] and electroporated after incubation at 45·c (approximately 
119 transformants/µg of DNA) is nearly three-fold that of cells grown in M7H9 + OADC 
(approximately 39 transformants/µg of DNA). 
67 
Table 2. The mass of total ASLs isolated from 250 mL of each culture. 
Culture 
M ulcerans mutant #115, a PKS 
knock-out mutant 
M ulcerans Grown in Reid' s 
Synthetic Medium 
M ulcerans Grown in Sauton' s 
Synthetic Medium 
M ulcerans Grown in M7H9 + 
OADC 
M ulcerans Grown in M7H9 + 
2[0ADC] 
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Mass of Total ASLs Isolated 
From 250 mL of Culture 
(mg) 
.7847 
2.7456 
2.5867 
3.5133 
5 .3447 
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Figure 20. TLC analysis of ASLs isolated from a mycolactone-negative M. ulcerans 
PKS knock-out mutant 115 grown in M7H9 + OADC, M. ulcerans grown in Reid's 
synthetic media, Sauton's synthetic media, M7H9 + OADC, and M7H9 + 2(OADC]. 
ASLs were resuspended in acetone, and approximately 60 µg of each was loaded. The 
standard is 30 µg of previously isolated ASLs. The solvent system used was 90 : 1 0: 1 
chloroform:methanol:water (vol:vol:vol). 
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M. ulcerans Grown in M7H9 + 2 [0ADC] 
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Figure 21. Average number of transformants resulting from electroporations of M. 
ulcerans grown in M7H9 + 2[0ADC] at each temperature. 
Average was computed from sample size n = 3 .  Error bars represent ± 1 standard 
deviation. 
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Discussion 
The attempts to construct a mycolactone-negative mutant of M ulcerans via 
transpon mutagenesis discussed in the previous chapter were greatly hindered by the poor 
transformation efficiency of M ulcerans. For transposon mutagenesis to be a valuable 
tool with regard to this organism, it was necessary to determine the parameters under 
which transformation could consistently be carried out. In addition, it was certain that a 
reliable method for transforming M ulcerans would be highly useful, if not necessary, in 
future genetic analysis of this organism. While electroporation is considered the best 
method of transformation for any mycobacteria, including M ulcerans; there are no 
published reports of successful electroporation into it ( 40). At the time these studies 
were begun, the electroporation efficiency of this organism was effectively 0 
transformants/µg of DNA. A round of electroporation utilizing all aliquots of M 
ulcerans obtained from the washing of a 500 mL culture would yield a total of less than 
ten transformants but often none at all. 
Initially, it was necessary to determine what parameters of the pulse used in 
electroporation would yield the highest transformation efficiencies. Previously, several 
transformants of M ulcerans had been obtained at Rocky Mountain Laboratories through 
electroporation at 2.5 kV, 25 µF, and 800 n, parameters used for the electroporation of 
M tuberculosis and other related species. Because it is known that for other species 
higher resistances generally yield higher electroporation efficiencies as long as they do 
not result in arcing, the task of determining if a higher resistance used on M ulcerans 
would yield a higher electroporation efficiency was undertaken. Because even small 
amounts of impurities in DNA stocks can lead to arcing due to increased conductivity, it 
7 1  
is important to use the smallest volume of DNA possible during each pulse, usually 1 µL. 
Three sets of three identical aliquots each of 10% glycerol washed M ulcerans were 
electroporated with 1 µL ofEZ::TN™ <KAN-2>Tnp Transposome™ at constant 
capacitance and voltage, but a resistance of 800 n, 900 n, or 1000 n. This experiment 
yielded no transformants; therefore, it could not be determined with certainty which 
resistance would be best to use in future experiments. Every aliquot pulsed at 1000 n 
arced; while, one aliquot pulsed at 900 n arced. The sparse and greatly delayed growth 
on the non-selective control plates of the aliquots subjected to arcing indicated that 
massive cell death occurs among M ulcerans cells exposed to arcing during 
electroporation as it does for other species. As in other species, massive cell death is 
likely to greatly decrease electroporation efficiencies. It was decided to use 800 n 
resistance in all subsequent experiments; because, there was no arcing when pulsing the 
aliquots at this resistance, and non-selective control plates developed lawns within four 
weeks, demonstrating that the cells could recover when pulsed at this resistance. 
In the preliminary experiment to determine if the temperature of the M ulcerans 
cell at the time of electroporation might influence electroporation efficiency, aliquots of 
electrocompetent M ulcerans were held at three temperatures, 1) 4t, 2) room 
temperature, and 3) 37t, for 10 minutes prior to electroporation with .3 µg of the 
hygromycin B resistance conveying plasmid pPR27HI. No transformants resulted from 
aliquots electroporated after incubation at either 4t or room temperature. Though for 
statistical purposes more trials were needed, the results of this experiment suggested that 
an increase in temperature results in an increase in electroporation efficiency. The 
electrocompetent cells used in this experiment were prepared at room temperature. 
72 
Because no arcing occurred during this experiment, it appeared that washing cells at 
room temperature is at least as effective at producing electrocompetent cells as washing 
on ice at 4t. Washing cells at room temperature is a more convenient method, because it 
can be done without ice. It should also be noted that M ulcerans cells are less likely to 
clump together at a warmer temperature, making them easier to manipulate at room 
temperature than at 4t. Salts, which cause arcing, are trapped in clumps; therefore, the 
salts within non-clumped cells can be removed more efficiently than those within 
clumped cells. Electrocompetent M ulcerans cells were prepared at room temperature 
for all subsequent experiments and were never again electroporated at 4t. 
In the following experiment, a higher range of temperatures was used and more 
aliquots were electroporated at each temperature. The data obtained from this experiment 
suggests that to obtain the optimal electroporation efficiency, M ulcerans should be 
electroporated after incubation at 55t. Cells electroporated after incubation at 37t 
showed a slight but significant increase in electroporation efficiency when compared to 
those electroporated after incubation at 25t. While cells electroporated after incubation 
at 40" C and 45· C both had higher average number of transformants/µg of DNA than those 
electroporated after incubation at 3 7t, this increase was not statistically significant due to 
the great variability among the number of transformants which arose from each aliquot. 
The average number of transformants which arose from electroporations after incubation 
at 55t was five-fold higher than that achieved after incubation at 37t. Further tests 
might be valuable to determine if even higher temperatures may increase electroporation 
efficiency more; however, in a separate study ( data not shown), M ulcerans cells held at 
65t for ten minutes prior to electroporation were completely killed. (I.e., They failed to 
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grow-up at all, even on non-selective M7H9 + OADC.) Therefore, it is likely that a 
temperature which after incubation at induces a higher electroporation efficiency, if not 
55t, is between 55t and 65t. 
Electroporation efficiencies of over 100 transformants/µg of DNA achieved when 
cells are electroporated after incubation at 55t represent an enormous improvement over 
the very poor and unreliable electroporation efficiencies ( always less than 10 
transformants/µg of DNA and often none at all) achieved with the protocols used at the 
time this study was begun. It is likely that increasing temperature of the M ulcerans cell 
increases the fluidity of lipids in the cell wall. Though usually impervious to the effects 
of electroporation, the M ulcerans cell wall of increased fluidity would be more likely 
upon electroporation to form the pores necessary for transformation. This phenomenon 
of increased electroporation efficiency with increased temperature of the cell was tested 
for another atypical mycobacteria with a lipid-rich cell wall-M fortuitum. A similar 
trend was seen for M fortuitum, also a bacterium for which a reliable electroporation 
protocol has not been developed. For this bacterium, the electroporation efficiency after 
incubation at 45t, approximately 1,173 transformants/µg of DNA, was greater than ten­
fold higher than that after incubation at 40t, 106 transformants/µg of DNA. 
It is thought that a great hindrance to transformation of M ulcerans is its thick, 
polyketide-enriched cell wall. In order to determine if electroporation efficiencies could 
be increased by decreasing the amount of lipids and particularly the amount of 
mycolactone produced by the organisms, a series of experiments were performed to 
compare the mass of ASLs produced by and the electroporation efficiencies of the 
following cultures: 1) M ulcerans grown in M7H9 + OADC, 2) M ulcerans grown in 
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M7H9 + 2[0ADC], 3) M ulcerans grown in Reid's synthetic media, 4) M ulcerans 
grown in Sauton' s synthetic media, and 5) a mycolactone-negative PKS mutant 115 of M 
ulcerans. Equal portions of each culture were used to 1) repeat the electroporation 
experiment previously described and 2) extract ASLs. As expected, the cultures grown in 
Reid's and Sauton' s synthetic media produced a significantly smaller mass of AS Ls than 
did the cultures grown in M7H9 + OADC; while, the culture of mutant 115 produced an 
even smaller mass of ASLs. Also as expected, M ulcerans grown in M7H9 + 2[0ADC] 
produced significantly more ASLs than did M ulcerans grown in M7H9 + [OADC]. 
Despite the decrease in ASL production of cultures grown in Reid's and Sauton' s 
synthetic media and the culture of mutant 115 grown in M7H9 + OADC, there was no 
increase in electroporation efficiency seen. In fact, no transformants resulted from these 
three electroporation studies. However, it can not be said with certainty that a decrease in 
mycolactone (and total ASL) production by some other means would not improve 
electroporation efficiencies. Sauton's synthetic and Reid's media both lack oleic acid, a 
major component of OADC. Including oleic acid in the growth medium of mycobacteria 
is known to increase the total percentage of lipids composing the cell ( 66). This is 
thought to account for the increase in AS Ls seen for cells grown in M7H9 + 0 ADC and 
the even greater increase in ASLs for cells grown in M7H9 + 2[0ADC] . It can only be 
said with certainty that PKS mutant 115 and wild-type M ulcerans grown in either 
Reid's or Sauton' s synthetic media all have electroporation efficiencies far lower than 
electroporation efficiencies of wild-type M ulcerans grown in M7H9 + OADC. It should 
be noted that mutant 115 appears to have a much slower growth rate than wild-type M 
ulcerans 1615, requiring nearly twice as long to reach log phase. It is interesting to note 
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that while the M7H9 + OADC and M7H9 + 2[OADC] cultures have comparable 
electroporation efficiencies after incubation at 25t, 3 7t, and 40t, the electroporation 
efficiency of the M7H9 + 2[OADC] culture after incubation at 45t is three times that of 
the electroporation efficiency of M7H9 + [OADC] culture. An additional experiment has 
been performed to determine if there is a significant difference between the 
electroporation efficiencies of the two cultures after incubation at higher temperatures 
(particularly after incubation at 55t). 
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V. The Investigation of a Link between Mycobacterium ulcerans and 
Schistosome-Inf ected Snails 
Introduction 
The natural reservoir of Mycobacterium ulcerans is unknown. Though many 
attempts had been made; at the time this study was begun, M ulcerans had never been 
isolated from the environment, not even from Buruli ulcer-endemic foci (19, 69). 
Despite this deficiency in evidence needed to construct a complete model of M ulcerans 
infection, most researchers believe that M ulcerans infections are in fact acquired from 
the natural environment, particularly through small injuries which puncture the skin 
allowing the bacteria access to the subcutaneous layer of fat (19, 53, 81). Such injuries 
may be so small that the patient may not remember having them by the time the infection 
is obvious. 
There is significant data to suggest that infection with M ulcerans is acquired 
through water. M ulcerans has been detected via PCR from water samples taken in 
Buruli ulcer-endemic regions; while, no other environmental samples unassociated with 
water have been consistently PCR-positive for M ulcerans (68, 71). However, the theory 
that M ulcerans is acquired through contact with contaminated water is more supported 
by epidemiological data. One study reported on the high incidence of M ulcerans 
infection among Rawandan refugees who had recently settled in the refugee settlement of 
Kanyara, Uganda located near marshy areas near the Nile river (47). Buruli ulcer was 
not prevalent in Rawanda; so, it was unlikely that the refugees brought the disease with 
77 
them. It was also unlikely that the refugees acquired Bundi ulcer from the other 
inhabitants of Kanyara, because there was little contact between the refugees and the 
other inhabitants. When the refugees were relocated to Kyangwali, a new area much 
further from the marshy land of the Nile, the incidence of Buruli ulcer greatly decreased 
within months, then virtually disappeared (2). 
Similarly, in 1997 Ross, et al., reported on an outbreak of Buruli ulcer in a small 
town on Phillip Isla'.nd of Australia that seemed to be centered around the irrigation 
system of a golf course (69). The irrigation system relied on water from a storage dam, 
which contained natural ground water and treated wastewater. The outbreak was 
preceded by the construction of a road which prevented nearby land from draining 
naturally, consequently creating a swamp. Before this outbreak, the town had had no 
previous cases ofBuruli ulcer. It is believed that this manmade swamp may have 
provided a suitable environment for the growth of M ulcerans and contaminated the 
irrigation system (69). Both the swamp and irrigation tank were PCR-positive for M 
ulcerans; while, other environmental samples were not ( 69). The incidence of Buruli 
ulcer in this town greatly decreased after the source of water for the irrigation of the golf 
course was switched to an alternate source (76). These and other epidemiological 
studies have led to almost universal acceptance that infection with M ulcerans is 
associated with rivers, streams, swamps, lakes, flooding, and possibly other natural and 
manmade bodies of water (7, 34, 58). 
It is not feasible for people living in Buruli ulcer-endemic regions to prevent the 
disease by avoiding contact with bodies of water suspected of harboring M ulcerans, 
because they may be dependent on them for their livelihood. If a practical plan for the 
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prevention of Buruli ulcer disease is to be created and implemented, more must be 
learned about its transmission in relation to water. This objective may be accomplished 
through the examination of correlations between Buruli ulcer disease and other factors 
related to water. One such factor was noticed in regions of West Africa where the 
incidence of Buruli ulcer has increased drastically, especially in areas adjacent to newly 
constructed river dams. In these same regions, there has also been a concurrent increase 
in schistosomiasis (87). 
Schistosomiasis, or Bilharziasis, is an infection caused by digenetic trematodes of 
the genus Schistosoma. There are primarily three species which cause disease in humans: 
S. haematobium, the most common cause of schistosomiasis in Africa and the Middle 
East; S. mansoni, which is prevalent in Africa and Central and South America; and, S. 
japonicum, which is prevalent in the Far East (57). Two other less prevalent species of 
schistosomiasis are S. intercalatum and S. mekongi, which are limited to West Africa and 
South East Asia, respectively (10, 37, 75). Schistosomes become associated with water 
when their eggs are released into it through contamination with waste of an infected 
human (Figure 22). The eggs hatch in response to fresh water to release miracidia-the 
life stage of the schistosome infective to snails, the intermediate hosts of the schistosome. 
Only when the permissive species of snail is present can the miracidia of a specific 
species of schistosome establish an infection in the snail and continue its life cycle. At 
this stage in the life of a schistosome, asexual reproduction is carried out. A miracidium 
forms a primary sporocyst in the snail from which forms a secondary sporocyst. Each 
secondary sporocyst gives rise to thousands of cercariae--the larval stage infective to 
humans. 
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Schistosome eggs are deposited in water when the water is contaminated with the waste 
of an infected host (1). These eggs hatch, releasing miracidiae (2). Miracidiae infect 
snails (3). Each miracidia gives rise to a primary sporocyst, which gives rise to a 
secondary sporocyst (4). Cercariae are released from daughter sporocysts (5) and infect 
humans by penetrating the skin (6). After penetration, the cercariae become 
schistosomulae (7) and enter the circulation of the host (8). Schistosomulae mature into 
adult schistosomes in the liver of the host (9). They then migrate as sexually reproducing 
pairs to veins lining the intestines or bladder, depending on the species (10). (Adapted 
from CDC DPDx, 2004.) 
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Cercariae infect their definitive hosts by burrowing into the skin. Upon 
penetration, the cercariae loose their tails to become schistosomulae which enter the host 
circulatory system. The schistosomulae develop into adult worms up to 20 mm long in 
approximately one month. A male and female worm pair together and reside in the 
vessels lining the intestine or bladder, depending on the species of schistosome. At this 
stage, the schistosomes reproduce sexually. Each pair can excrete from several hundred 
to one thousand eggs everyday for an average of five years. Many of these eggs get 
excreted in the urine or feces of the host to complete the cycle of infection. Many eggs 
are not excreted and remain in the host causing an inflammatory response which over 
time damages vital tissues of the host. 
It is this very inflammatory response that some researchers have blamed for the 
concurrent increases in Buruli ulcer disease and schistosomiasis. It is known that 
infection with schistosomiasis drives the host immune system toward a Th2 immune 
response while dampening the Thl response (77). It has been demonstrated that the 
development ofBuruli ulcer disease is likely to be fostered by anergy ofThl 
lymphocytes (26, 27). A change from a Th 1 immune response to a Th2 response 
following the development of Buruli ulcer disease has also been documented in a patient 
(28). For these reasons, it has been postulated that being infected by schistosomes 
predisposes patients to the development of Buruli ulcer disease (70, 87). 
The following experiments were undertaken in an effort to test a different but 
related hypothesis. We wanted to determine if snails, the intermediate hosts of 
schistosomes, could harbor and transmit M ulcerans. Because no specific element of the 
ecological niche of this bacterium had been identified at the time of these studies, it was 
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thought that even negative data on this subject would be valuable. In addition, we 
wanted to determine if there was an association between cercariae and M ulcerans. 
Because the cercariae that infect humans must burrow into the skin, they may simply be 
responsible for the penetrating injury thought to be required for M ulcerans to cause an 
infection. It is plausible that M u/cerans is actually associated with the cercariae as is the 
bacterium, Neorickettsia (Ehrlichia) risticii-the causative agent of Potomac horse fever 
(62). 
Results 
Infection of Snails with M. ulcerans 
In order to determine whether snails could be infected with M ulcerans, 
six snails of the species Biompha/aria g/abrata were placed in 25 mL of sterile, 
conditioned water to which 2.5 mL of M ulcerans 1615 culture was added. As a control, 
six snails of the same species were placed in 25 mL of sterile, conditioned water to which 
2.5 mL ofM7H9 + OADC was added. After 24 hours, all snails in both the infection and 
control groups had died. Upon examination with the naked eye and low power dissection 
scope, the six snails in the infection group (I 1-16) had no apparent tissue damage that 
might be attributed to contact with mycolactone ( or any compound within the medium). 
Likewise, the six snails of the control group (Ul-U6) had no obvious change in 
appearance. In preparation for the examination of the snails for an association with M 
ulcerans, all snails were rinsed repeatedly with sterile water and treated with amikacin for 
36 hours, which is effective at killing extracellular M ulcerans. Each snail was ground in 
a sterile tissue grinder, and the homogenate was divided into two portions: one for total 
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genomic DNA isolation and the other for treatment with a decontamination protocol 
aimed at eliminating all bacteria other than mycobacteria. The total genomic isolations 
produced a very small amount of DNA which was too dilute to be visualized via 
electrophoresis. However, this DNA proved to be suitable for PCR. Total genomic DNA 
isolations from all six infected snails (11-16) were PCR-positive for the 1S2404 insertion 
element specific to M ulcerans; while, the total genomic DNA isolations from all six 
uninfected snails (Ul -U6) were PCR-negative for 1S2404 (Figure 23). The plating of 
decontaminated snail tissue resulted in a multititude of bacterial colonies diverse in 
morphology {Table 3). Plates of snails 3 and 4 of the infectious group (13 and 14) and 
snails 1 and 2 of the control group (Ul and U2) resulted in many colonies after two 
weeks that contained acid-fast bacteria. Though M ulcerans will not grow up on a plate 
in two weeks, these acid-fast colonies were analyzed via PCR for the presence of 1S2404. 
None were found to be PCR-positive for this insertion element; therefore, the possibility 
of them being M ulcerans was eliminated. 
Infection of Schistosome-Infected Snails with M. ulcerans through 1) 
Environmental Inoculation and 2) Foodborne Inoculation 
In order to determine if schistosome-infected snails could be infected with 
M ulcerans, two related infection studies were performed: 1) environmental infection 
and 2) foodborne infection studies. For both studies, two groups of ten snails of the 
species B. glabrata infected with S. mansoni were used. To allow for the schistosome 
infection to develop, these snails were maintained for four weeks before infection. The 
inoculum used for each of the two infections was washed with sterile water to remove 
any compounds within the medium which would result in immediate death of the snails. 
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Figure 23. Detection of 1S2404 via PCR in total genomic DNA isolations of M. 
ulcerans-infected snails (11-16) and uninfected snails (Ul-U6). 
All total genomic DNA isolations of infected snails are PCR-positive for ·1s2404, 
indicative of M ulcerans; while, all total genomic DNA isolations of uninfected snails 
are PCR-negative for this element. 
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Table 3. Characterization of growth resulting from the plating of 
decontaminated tissue from the preliminary infection of snails of the species 
Biomphalaria glabrata. 
Snail Plated Description of Growth and Time of First Acid-Fast 
Appearance 
I 1 1  None NIA I 
12 One large, cream-colored colony appeared after two weeks. -
13 One large, cream-colored colony appeared after two weeks. + 
I 
Infected 14 ! One large, cream-colored colony appeared after two weeks. + Group 
I 
15 Plate was overgrown with a lawn of I) cream and 2) rose- -
i colored microorganisms that extend into the agar after one 
week. 
16 Two small areas with rose-colored growth similar to that of 15 -I-
were observed after one week. Four smooth, white colonies 
were observed after four weeks. These colonies were not 
morphologically similar to M ulcerans and appeared to be 
yeast. 
Ul  ii Three large, shiny, white colonies appeared after one week. + 
� I I 
U2 Twenty large, shiny, white colonies which were + 
morphologically similar to those ofUl  appeared after one week. 
U3 One smooth, shiny, yellow colony appeared after four weeks. -
Control 
Group U4 One large, shiny, white colony and a lawn of rose-colored -
I growth appeared after one week. 
I I us One large, shiny, white colony appeared after one week. -
U6 None NIA 
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For the environmental infection, the 10 snails of the infection group were placed in 250 
mL conditioned water to which 2 mL of washed M ulcerans culture was added; while, 
the 10 snails of the control group were held in 252 mL conditioned water. For the 
foodborne infection, the 10 snails of the infection group were held in 250 mL conditioned 
water where they were fed 1 g of food supplement which served as a matrix for the 
bacteria from 2 mL of washed M ulcerans culture; while, the 10 snails of the control 
group were held in 250 mL conditioned water where they were fed 1 g of sterile food 
supplement. After 24 hours, all four experimental groups were returned to their 
respective containers and maintained as usual for eight weeks. Both groups tolerated 
infection well, and there were few premature deaths. Snails were divided relatively 
equally into two groups: 1) those to be preserved for the preparation of histological slides 
and 2) those to be homogenized, decontaminated, and plated. 
The prepared histological sections proved to be an unreliable source of data. It 
was very difficult to discern the anatomy of the snail when viewing the sections which 
had been acid-fast stained. No difference between either infection group or their 
respective controls could be substantiated. Many regions on every snail for both 
infection studies and their respective controls had the appearance of acid-fast bacilli. 
The plating of snail tissue proved to be a more valuable source of data in these 
experiments. A moderate array of microorganisms survived the decontamination 
procedure and grew up on the plates from snails from both infection groups as well as 
their respective controls (Table 4 and Table 5). At least one representative colony from 
every descriptive group of microorganisms on each plate was acid-fast stained. As noted 
in Tables 4 and 5, many of these colonies were acid-fast. Colonies that were acid-fast 
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Table 4. Characterization of growth resulting from the plating of decontaminated 
tissue from the infection of schistosome-inf ected snails of the species B. glabrata with 
M. ulcerans through environmental inoculation. 
Snail Plated Description of Growth and Time of First Acid-Fast 
Appearance 
EMul Many small, bright yellow colonies appeared after two + 
weeks. 
I 
EMu2 Many small yellow colonies morphologically identical to +/-/-
those ofEMul (acid-fast); three large, shiny white colonies 
(non-acid- fast); and 2 bright orange colonies (non-acid-fast) 
all appeared after two weeks. 
Environmentally 
Infected Group EMu3 Many yellow colonies identical to those ofEmul (acid-fast); +/-/+ 
several bright orange identical to those of EMu2 (non-acid-
fast); and many small white colonies (acid-fast) appeared 
after two weeks. 
Emu4 I Many yellow colonies identical to those ofEmul (acid-fast); +/-/-
several bright orange identical to those of EMu2 (non-acid-
I fast); and several white colonies (non-acid-fast) all appeared 
1 after two weeks. 
EC2 Several bright yellow colonies identical to those of EMu 1 ,  +/-/-
I 
etc. (acid-fast); several white colonies (non-acid-fast); and 
several bright orange colonies identical to those of Emu2, 
I etc. (non-acid-fast) all appeared after 2 weeks. 
EC3 Several bright yellow colonies identical to those of EMu 1 ,  +!-/-
Environmental 
etc. (acid-fast); several white colonies (non-acid-fast); and 
several bright orange colonies identical to those of Emu2, 
Control Group I etc. (non-acid-fast) all appeared after 2 weeks. 
EC4 Several bright yellow colonies identical to those of EMu 1 ,  +/-/-
etc. (acid-fast); several white colonies (non-acid-fast); and 
1 several bright orange colonies identical to those ofEmu2, etc. (non-acid-fast) all appeared after 2 weeks. 
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Table 5. Characterization of growth resulting from the plating of decontaminated 
tissue from the infection of schistosome-infected snails of the species B. glabrata with 
M. ulcerans through foodborne infection. 
Snail Plated Description of Growth and Time of First Acid-Fast 
I 
Appearance 
FMul I White and reddish slimy overgrowth of plate after one week. -
FMu2 Many small, bright yellow colonies and several large, white, dry +/+ 
colonies appeared after two weeks. 
I 
FMu3 Many white colonies identical to those ofFMu2 (acid-fast) and +/-1 a slimy lawn very similar to that ofFMul (non-acid-fast) 
Food 
apparent after two weeks. 
Infected FMu4 Many small, yellow colonies identical to those of FMu2, etc. +/-Group (acid-fast) and eight large, shiny white colonies (non-acid-fast) I 
I apparent after two weeks. 
FMu5 Similarly to those of FMu2, etc., many small, bright yellow +/+ 
colonies and several large, white, dry colonies appeared after 
two weeks. 
FMu6 Many small, bright yellow colonies; several large, white dry +/+!-
colonies; and one bright orange colony (non-acid-fast) appeared 
I after two weeks. 
i
1 
FCI Several yellow colonies like those ofFMu2, etc. (acid-fast) and +/-
one large purple colony (non-acid-fast) appeared after two 
weeks. 
Food 
FC2 Several yellow colonies like those ofFMu2, etc. (acid-fast) and +!-
Control several white colonies (non-acid-fast) appeared after two weeks. 
Group I 
I FC3 Similar to FMu6, many small, bright yellow colonies; several +/+!-
large, white dry colonies; and several bright orange colonies 
(non-acid-fast) appeared after two weeks. 
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were analyzed via PCR for the presence of the 1S2404 insertion element used to identify 
M ulcerans. None were PCR-positive for the presence of this insertion element. 
Therefore, no M ulcerans was recovered from the schistosome-infected snail in either 
infection study. 
Discussion 
In the preliminary snail infection, all snails in both the infection and control 
groups died with in 24 hours. Though mycolactone is likely to be harmful to snails, this 
was not the sole cause of death; because, snails in the control group did not come in 
contact with mycolactone. However, all snails did come in contact with M7H9 + OADC 
medium. It was clear that for any future studies designed to determine the effect of M 
ulcerans on snails, the M ulcerans used must be washed clean of the media before 
coming in contact with the snails. 
In an effort to obtain PCR data with regard to the ability of M ulcerans to infect 
snails as a part of the preliminary infection study, it was found that PCR reactions were 
inhibited by the presence of even very small quantities of the ground snail tissue used as 
template even after the sample was boiled. Dr. Fred Lewis ofBRI reported (personal 
communication) that those is his lab had been successful at isolating total DNA from 
snail specimens for the purpose of PCR using the Wizard® Genomic DNA Purification 
Kit. The DNA obtained from this kit was too dilute to be visualized by electrophoresis. 
However, it did prove to be suitable for PCR. Because snails had been submersed in a 
solution of amikacin for 36 hours, this is suggestive that the M ulcerans may be 
somehow internalized. It was clear that further studies aimed at histological examination 
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of the snail after a period of time sufficient enough for M ulcerans to establish an 
infection would be valuable in confirming this. 
It was thought that several problems with the decontamination protocol used for 
plating snail tissue during this preliminary study may have resulted in the killing of M 
ulcerans indicated by PCR to be present in the snails of the infection group (11-16). The 
sample volumes were too small to neutralize quickly, and the pH paper proved to be an 
inefficient and cumbersome way of determining when the solution was neutralized. It is 
likely that the pH remained too high for too long to allow the survival of many 
mycobacteria that may have been present. Despite the difficulties in decontamination, 
plates of snails 3 and 4 of the infectious group (13 and 14) and snails 1 and 2 of the 
control group (Ul and U2) resulted in many colonies after two weeks that were acid-fast; 
however, none were confirmed to have the 1S2404 insertion element indicative of M 
ulcerans. Plates were incubated for three additional months to allow for slow growing 
mycobacteria to appear; however, no new colonies appeared after the first two weeks of 
incubation. These colonies which had appeared had similar morphology and color and 
probably represent a mycobacterium species ( or other relatively slow growing acid-fast 
bacterium) that is part of the normal flora of the snail. The existence of such organisms 
as a part of the normal flora of B. glabrata has been reported (55). 
Because snails in the natural environment in areas where Buruli ulcer is endemic 
are intermediate hosts of schistosomes and play an integral role in the transmission of 
schistosomiasis, it would be more valuable to examine schistosome infected snails. The 
true aim of these studies is to examine any interaction between schistosome infected 
snails and M ulcerans. For this reason, in the 1) environmental infection and 2) food-
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borne infection studies S. mansoni infected snails of the species B. glabrata were used. 
To allow for the schistosome infection to develop, these snails were maintained for four 
weeks before infection. Washing the inoculum of M ulcerans with sterile water 
prevented the immediate snail death observed in the preliminary infection study. 
Because the isolation of genomic DNA significantly decreases the amount of snail 
homogenate available for decontamination and plating, it was determined that for these 
studies no total genomic isolations would be undertaken; and thus, no snails from this 
study would be evaluated via PCR. Snails were either 1) fixed and prepared in sections 
or 2) ground, decontaminated, and plated. Unfortunately, the prepared sections proved to 
be an unreliable source of data. It was very difficult to discern the anatomy of the snail 
after acid fast staining. Many regions on every stained snail section from both infection 
studies and their respective controls had the appearance of acid-fast bacilli. No 
difference between either infection group or their respective controls could be 
substantiated by evaluation of the histological slides made. The plating of snail tissue 
proved to be a more valuable source of data in these experiments. The use of the pH 
indicator solution (rather than using pH paper) allowed a more accurate and quicker 
neutralization; however, no M u/cerans was recovered. It is not clear if this was due to a 
still too harsh decontamination protocol or to the overgrowth of other organisms on the 
plates. 
During the time that this work was being done, it was determined in several other 
labs that snails could not be persistently infected with M u/cerans. Further 
epidemiological studies have shown no connection between schistosomiasis and Buruli 
ulcer. As a result, these studies have been discontinued. 
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VI. Conclusion 
Efforts to create a mycolactone-negative mutant of Mycobacterium ulcerans via 
transposon mutagenesis were undertaken to elucidate the genes involved in the 
production of this toxin. Though only five PCR-confirmed mutants were produced, one 
of these, mutant 1615:tnp6w, was confirmed to be deficient in mycolactone production 
via thin-layer chromatography of acetone soluble lipids, cytopathicity assay of culture 
filtrate on L929 murine fibroblasts, and mass spectroscopy of ASLs. This mutant was 
found to contain an insertion near the upstream end of a gene 97% identical to the M 
marinum fur A gene but within a region of DNA not homologous to any other known 
prokaryotic gene. It was thought that this insertion may be interrupting the transcription 
of the fur A homologue, because an additional mycolactone-negative mutant of M 
ulcerans (mutant 97) independently created was found to have an insertion with in the 
structural gene of the/urA homologue. However, the production of mycolactone was not 
restored when the mutant 1615 :tnp6w was transformed with a construct containing the 
fur A homologue of M ulcerans. PCR analysis for the presence of genes recently found 
to be essential for the production of mycolactone revealed a deletion of such an essential 
gene-one encoding a thioesterase (II). The absence of this gene is the most probable 
and immediate cause of the mycolactone-negative phenotype. To further investigate the 
role of FurA in the regulation of mycolactone production, further attempts to complement 
mutant 97 should be made. 
In an effort to determine the effect of temperature on the transformation 
efficiency of M ulcerans via electroporation, electroporation experiments were 
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performed on M ulcerans 1 6 1 5  grown in Middlebrook 7H9 with 10% oleic acid­
albumin-dextrose-complex supplement (M7H9 + OADC). Log phase cultures were 
harvested, washed with 10% glycerol, and apportioned into 60µL aliquots. Aliquots were 
briefly held at room temperature, 37t, 40t, 45t, or 55t before electroporation in the 
presence of 1 µg of pPR27H 1 ,  a hygromycin B resistance conveying plasmid. After 6 
weeks, colonies were counted to calculate transformation efficiencies. It was found that 
M ulcerans cells incubated at 55t prior to electroporation had a significantly higher 
transformation efficiency than those incubated at any other temperature prior to 
electroporation. 
To determine if the presence ofmycolactone affects electroporation efficiency, a 
similar experiment was repeated with M ulcerans grown in Modified Reid's synthetic 
medium and M ulcerans grown in Sauton's  synthetic medium, both media which are 
thought to promote a decreased production of mycolactone; M ulcerans grown in M7H9 
with 20% OADC supplement (M7H9 + 2[0ADC]), which is believed to foster an 
increased production of mycolactone; and, a polyketide synthase (PKS) knock-out mutant 
of M ulcerans (mutant 1 1 5), which does not produce mycolactone, grown in M7H9 + 
OADC . M ulcerans grown in Reid's  or Sauton's synthetic media produced no 
transformants. M ulcerans grown in M7H9 + 2[0ADC] had a significantly higher 
transformation efficiency when incubated at 45t prior to electroporation than that grown 
in M7H9 + OADC and incubated at 45t prior to electroporation. Experiments to 
determine if M ulcerans grown in M7H9 + 2[0ADC] and incubated at higher 
temperatures ( 55t and 65t) prior toelectroporation will result in even higher 
electroporation efficiencies have been performed; however, the results are not available. 
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Finally, though the natural reservoir of M ulcerans is unknown, Buruli ulcer 
disease seems to be associated with water. For this reason, experiments aimed at 
investigating aquatic snails, also associated with water in Buruli ulcer endemic regions, 
as a component of the ecological niche of M ulcerans were undertaken. Snails of the 
species Biomphalaria glabrata are intermediate hosts of the schistosome species 
Schistosoma mansoni; and, it is feasible that M ulcerans could associate with cercariae, 
the schistosomal life stage infectious to humans, infecting humans through the wound 
caused by the cercaria entering its human host. Through various experiments, both 
healthy Biomphalaria glabrata and Schistosoma mansoni infected Biomphalaria glabrata 
were exposed to M ulcerans and examined for M ulcerans infection via PCR and plating 
of ground tissue. Though PCR analysis did indicate that the M ulcerans was taken up by 
the snail in some way, plating of the snail tissue as well as histological sectioning was 
inconclusive. Despite decontamination protocols, there were great numbers of other 
species as bacteria present on the plates which may have outcompeated the M ulcerans, 
which did not grow on the plates. Slides of snails infected with M ulcerans and of 
uninfected snails were indistinguishable when stained by either hematoxylin-and-eosin or 
acid-fast staining. To definitively determine if there is an association between M 
ulcerans and schistosome-infected snails, experiments involving fluorescently labeled 
antibodies against M ulcerans or M ulcerans expressing green-fluorescent protein would 
be useful. 
Mycobacterium ulcerans is an organism of relatively new and fervent interests. 
With Buruli ulcer having been recognized by the World Health Organism as an emerging 
threat, many groups have been working to answer many of the questions addressed in the 
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experiments described in this work. Significant advancements both in the identification 
of the primary genes involved in the production of mycolactone and in the identification 
of the ecological niche of M ulcerans have been published in the recent past. 
Most recently, Stinear, et al., reported that at least many, if not all, of the essential 
genes required for the production of mycolactone are located on a 17 4 kb plasmid that 
has been named pMUM00l (73). They describe two large polyketide synthases (PKS), 
MLSA 1 and MLSA2, which are responsible for the production of the 12-carbon core 
lactone; while, a third PKS, MLSB, is reportedly responsible for the side chain of 
mycolactone (73). The functions of these genes were assigned largely by data obtained 
from transposon mutants constructed by Dr. Armand Mve-Obiang using a phage delivery 
system which was found to be much more efficient at producing insertion mutants than 
the EZ::TN™ <KAN-2>Tnp Transposome™ Kit used previously to construct the 
mycolactone-negative mutant characterized in this work. While, still no definitive data is 
available on the role of Fur A in the production of mycolactone; the possibility of it 
serving a regulatory role can not be ruled out. 
Another important advancement in the knowledge of this organism was reported 
by Marsollier, et. al and contributes to the knowledge of the ecological niche of M 
ulcerans ( 49). This group has for the first time ever reportedly isolated M ulcerans from 
the environment. The organism was found in insects collected from Bundi ulcer­
endemic regions of West Africa. These insects of the genus Naucoris were found to have 
salivary glands colonized by M ulcerans ( 49). While the biting of insects carrying M 
ulcerans is likely to contribute to transmission of Buruli ulcer; other environmental 
sources of this organism need to be identified. Knowing a more complete picture of the 
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epidemiology of this organism will definitely prove beneficial for decreasing the incident 
of Buruli ulcer and preventing outbreaks. 
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